Issuu

ISSUE 3 Saturday 10 October 2026

DAILY NEWS

INNOVATE DISCOVER EDUCATE

The official newspaper of the 40th EACTS Annual Meeting 2026

PRESIDENTIAL ADDRESS

New EACTS President, Lorenzo Galletti We talk to EACTS' 41st President about his priorities, the future of congenital cardiac surgery and the opportunities presented by emerging technologies

4 Trial Update session In Memoriam: Professor David Taggart

6 Francis Fontan Fund Fellowships This year's Fellows share an update on their FFF experiences

9 Nursing and Allied Health Professionals in cardiothoracic surgery The session explores how nurses and allied health professionals continue to shape the future of surgical care

DO WHAT YOU CAN, WITH WHAT YOU HAVE, WHERE YOU ARE

n his Presidential Address, Rafael Sádaba reflects on decades of a career in medicine and the idea of purpose, and asks what can be achieved when resources, circumstances, and knowledge are not limitless. Drawing on some of the people who have shaped his career, he returns to a simple idea: that progress begins with making the most of what you already have. “Do what you can, with what you have, where you are.” It is a deceptively simple philosophy, but one that has come to define a career shaped as much by limitations as by ambition. The words are widely attributed to Theodore Roosevelt, the 26th President of the United States of America. For a surgeon, a scientist and a teacher, the question is not always what might be possible with unlimited resources. It is what can be achieved with the resources, knowledge and opportunities already at your disposal.   That question has followed Rafa Sádaba throughout his career, and his relationship with EACTS – a relationship that reaches back

to 5 September 1999, Rafa’s EACTS birthday. Rafa opened his Address with gratitude, and thanks the friends, family, colleagues and organisations that have supported him and made it possible for him to be here. Forty years later, the Association is no longer simply a professional organisation. It has become part of the story of how Rafa and thousands of EACTS members have grown - through friendships, colleagues, mentors, research, experiences, learning, and the shared pursuit of better care for patients. The Roosevelt quote is a powerful reflection that naturally leads to another question that Rafa poses directly to the audience. “Why do you come to work every day?” he asks. The answer, he suggests, is purpose. Rafa defines purpose as the reason our work exists and the unique contribution we make to the lives of others. The definition of purpose in the context of Rafa’s Address is broad. For surgeons and medical practitioners, that purpose is visible in the operating theatre and in the lives of the patients whose outcomes can be changed by their decisions. Continued on page 2

EACTS appointments from the General Assembly

EACTS 40 Under 40 Meet 40 inspiring EACTS members who go above and beyond to drive forward our mission of improving patient outcomes

Robert Klautz Vice-President

Joseph Bavaria Treasurer

Julia Dumfarth Aortic Disease Domain Chair

Issue 3 Saturday 10 October 1

IN THIS ISSUE NEW! Pulse by EACTS

EACTS TV

Exhibition map and exhibitors list

Scientific programme

New EACTS members

Continued from page 1

10 14 16 17 18

41st EACTS Annual Meeting

For the scientist in the lab, and those who work in research, the purpose is to generate impactful knowledge that informs practice, drives technological innovation, and enhances patient outcomes. "For those not in the field, the same applies. Why do you get up every morning? What can you do, and what are you contributing to others?" From there, Rafa moves in another direction: what happens when purpose meets constraint? Limitations are part of every career and every institution. Some are external, such as money, time, equipment or geography. Others are internal, such as selfdoubt or the assumptions we make about what is possible. There will always be limitations, but they do not have to define the outcome or what we strive to achieve. The danger comes when we accept them too readily, because in doing so we risk narrowing the possibilities and squandering our potential. To fulfil our purpose, we must not justify our limitations. Instead, we should do what we can, with what we have, where we are. Aiming high, even if you may not reach your final objective, is always worth it, and that is what Rafa tries to do. One of Rafa’s most powerful examples is Dr Norberto González de Vega, an 88-year-old Spanish surgeon who spent time training at the Leeds General Infirmary, the very same hospital where Rafa would train many years later. Dr González de Vega's work offers a striking example of what can happen when an idea is pursued with fierce determination despite severe limitations. Although his technique became widely used in cardiac surgery and is still recognised for its simplicity and efficacy, the man who designed it has not received the same level of international recognition as others. Dr González de Vega's story is not one solely of technical achievement, but a reminder that influence does not always belong to the person with the largest institution, the greatest resources or the highest profile. Inspired by those who achieved so much with few resources, Rafa explained his own experience at his centre in Spain: "Our hospital is at a mid-level in terms of volume, but with teamwork, and proper preparation and

communication, our team has developed a complete programme with excellent results." At a scientific level, the original team of two, which started with very limited resources, has grown into a successful team of more than 20 physicians and scientists with their own laboratory research programme. ‘Where you are’ is not a limitation, but a starting point.   ‘What you have’ is not a list of everything you lack, but an inventory of what can be used. ‘What you can’ is ultimately a question of responsibility.   This year marks the milestone 40-year anniversary of EACTS, and Rafa pays tribute to the grandfathers who had minimal resources, plenty of limitations, and did what they could. Their generation worked without many of the technologies, resources and accumulated knowledge that surgeons today may take for granted. They had fewer tools and answers, yet they built the foundations on which others could later stand. A video was then presented of Rafa and colleagues discussing what purpose means to them. It brought the theme out of the abstract and into the voices of people doing the work every day, showing that purpose is not a single, fixed idea but something shaped by patients, teams, mentors, challenges and responsibility. In that discussion, purpose becomes collective as well as personal: a reminder that medicine advances through shared commitment. Rafa’s message is not one of foolproof achievements, but of a way of working with purpose and making progress without waiting for perfect conditions. Limitations exist, but they don’t have to be the end of the story. One person can’t change everything, but maybe you can meaningfully change one thing.

LIFETIME ACHIEVEMENT AWARD Dr Norberto González de Vega pioneered the “De Vega annuloplasty,” a simple and durable tricuspid valve repair technique that has been used worldwide for more than 50 years and remains widely taught and performed today. Developed in 1972 at the Fundación Jiménez Díaz in Madrid, his technique has been cited in hundreds of scientific publications and

major cardiology textbooks. His wider career includes pioneering cardiac surgery in Spain, international collaboration with leading centres, decades of high-volume operative practice, and sustained recognition from Spanish cardiovascular societies. The EACTS 40th anniversary provides an opportunity to recognise Dr de Vega’s enduring contribution to cardiac surgery and the global legacy of his work.

DOWNLOAD THE EACTS APP HERE

Being honoured with an award like this in the winter of my life is something wonderful - a tribute to all the mentors I was fortunate enough to learn from over the years, an unforgettable gift for my family to whom I owe so much, and a source of pride for my patients and all the colleagues-surgeons, cardiologists, anaesthesiologists, perfusionists, and nurses - who have accompanied me on a journey that, while not always easy, has been truly wonderful.

A SNAPSHOT OF SATURDAY'S SESSIONS 10:00 - 11:00 Room 115/116/117 Improving CABG outcomes in the OR

Live Translation 1. Scan the QR code using your personal device

https://attend.wordly.ai/join/XWJN-2581

2. Select your preferred language 3. Click attend If you wish to listen to the audio translation, please use your headphones and ensure that your device is unmuted.

2 EACTS DAILY NEWS

11:15 - 12:45 Room 113 Special session dedicated to J.V. Comas on transposition of the great arteries 11:15 - 12:45 Room 131-132 Nursing and Allied Health Professionals in cardiac surgery

11:15 - 12:45 Room 115/116/117 Trial Update Session – In Memoriam: Professor David Taggart 12:45 - 13:30 Room 115/116/117 Keynote Lecture with Toni Nadal

Lorenzo Galletti on becoming EACTS' 41st President

It is a privilege to be part of such an important scientific community.

Can you take us back to when you first became involved with the Association in 1999? What did EACTS mean to you then? I became an active member of EACTS in 1999 – the same year as our immediate past-President Rafael Sádaba - and over the years I became increasingly involved in the Association. Since 2003, I was regularly involved in presentations at the Annual Meetings. From 2013 to 2017, I was a board member of the Congenital Disease Domain and then Chairman from 2018 to 2021. This was my first involvement in the EACTS Council. I have also served on the Guidelines Committee and in Education Committee within the congenital field, and last year I returned to the EACTS Council as Vice-President. Over the past few decades, being part of such a large, international scientific community has been so special. EACTS is one of the largest cardiothoracic associations and, in my view, the most global society in our field. As a young doctor, having access to some of the most prominent people in the speciality and being able to discuss things with them is extremely important and stands to me today. EACTS has been important for my professional development. Throughout my residency, fellowships and career, I have had mentors within and outside the Association who were willing to give me advice. Being part of the EACTS community means having people around you who are prepared to share their experience and expertise – including what you should and shouldn’t do in surgical practice. As EACTS celebrates its 40th anniversary, what does becoming President mean to you? It is a great honour and a great privilege. I have been a member of many different societies across Europe and the USA, but to serve as President of the European association for our field is particularly important to me. EACTS is an incredibly global organisation. We have members and presenters from Europe, Asia, the United States, South America and many other parts of the world, and we continue to develop our relationships in Africa. The breadth of representation makes it a very special community, and it is an honour to serve as President at such an important moment in the Association’s history, as we celebrate 40 years. What are your biggest priorities for your Presidency? I think every President should leave some work behind and contribute something to the future of the Association. One of my strongest commitments is to education, and I would like to continue to work toward better skills, better surgery and, ultimately, better outcomes for everyone involved: professionals, patients and their families, as well as industry and the wider healthcare community. 4 EACTS DAILY NEWS

I would like to increase the level of educational activity in congenital cardiac surgery, with more practical and live courses, using clinical scenarios and simulation of procedures. Simulation is becoming increasingly important in training, because the traditional concept of simply developing through a long learning curve is no longer acceptable. We need to provide high-quality education regardless of where someone is in their career. Another important priority is the development of a database for paediatric and congenital cardiac surgery. We need better ways of evaluating risk and benchmarking procedures. The registries we have today do not always capture the differences between centres, and it is very difficult to compare outcomes without standardised evaluation. We have already started working on this, with members of the EACTS Quality Improvement Programme and Congenital Disease Domain, and a taskforce is in development. I want to continue EACTS's contribution to globalisation. We should strengthen our educational and scientific collaborations with national, international and supranational societies. My own experience of different languages and cultures (I spent a lot of time in Madrid, speaking Spanish) has helped me to build relationships, particularly in Latin America. You have been active in several major cardiothoracic societies, including AATS and STS. What have you learned from working across different organisations, and how can EACTS strengthen collaboration with other societies to advance cardiothoracic surgery? We already have a very strong relationship with the STS and have joint activities in Latin America (the EACTS/STS/LACES Latin America Cardiovascular Surgery Conference) and our inaugural conference in South Africa that just took place. We are also developing our collaboration in India (e.g. our joint meeting in Kolkata). The American societies have a different structure from EACTS. The STS, for example, is a very large society, but its membership is predominantly American, and people largely speak the same language. EACTS is highly diverse, linguistically and culturally. We represent around 50 countries, and that diversity influences the way we work. There is a lot we can learn from each other. The STS can give us efficiency, while EACTS can bring a more diverse and perhaps more artistic perspective in the way we run things. Those differences are strengths, and the collaboration benefits both organisations. You have spent most of your career in congenital heart surgery. What is it about the speciality that inspires you? I had to leave my country very early in my career to pursue this speciality. At the beginning of my studies, I wasn't even sure I wanted to become a surgeon. I thought surgery could be quite mechanical and perhaps less intellectual. When I discovered cardiac surgery, I realised it was probably the most medical of the surgical specialities, and congenital even more so. You need an enormous understanding of physiology, and you follow patients from newborn life through childhood and into young adulthood. That was fascinating to me. The interaction with children and their families is of course difficult, but it is also one of the things that pushed me towards this field.

What is the biggest threat to the future of congenital cardiac surgery today? And, conversely, what is the biggest opportunity for EACTS? One of the biggest opportunities is the new population of patients who have survived congenital procedures and are now reaching adolescence and adulthood. This creates new challenges, but also opportunities to strengthen collaboration with other areas of cardiac medicine and surgery. For example, congenital cardiac surgery has historically been less focused on valve disease, so the growing adult congenital population gives us an opportunity to collaborate more closely with colleagues working in valve surgery and other adult cardiac specialties. Innovation is another major opportunity. Organ preservation and organ regeneration are areas that we want to explore, and we have created the EACTS Innovation Summit to look at these types of developments. What opportunities do AI, robotics and other emerging technologies offer the next generation of surgeons? They present fantastic opportunities, but we need to be careful about how we use them. AI has enormous potential to support and help us, particularly in clinical decision-making, but it requires strong integration of data, which we are constantly working towards. AI will also play an important role in training and could help us assess surgical skills and provide objective feedback on performance. I see them as tools that can complement traditional training and help us understand how someone is progressing through a procedure. I would like to explore creating a stable platform for daily discussion and knowledge sharing, rather than relying solely on annual meetings. I still work with friends on particularly difficult cases, sharing information and experience to help make good decisions. Creating a platform where that kind of exchange

could happen more routinely would be valuable. We often hear the term ‘patient-centred care’. What does that mean in practical terms for a cardiothoracic surgeon? Putting the patient at the centre of our practice is something we do automatically, something I have always done. There can sometimes be a tension between Guidelines, how healthcare systems are organised and what is truly patient-centred. Ultimately, putting the patient first should be inherent to medical practice. What should EACTS be doing to attract talented young medical professionals into cardiothoracic surgery?

Meet Vice-President Robert Klautz Robert J.M. Klautz completed his medical training at the University of Leiden Medical School. After medical school, he spent two years as a research fellow at the Cardiovascular Research Institute of UC San Francisco from 1991–1993 after which he defended his PhD-thesis in Leiden on Cardiac Mechanics, specifically on single ventricle physiology.

Cardiothoracic surgery is sometimes viewed as a less attractive speciality. The training is long, and in congenital you may need at least 10 years before you are a fully trained, independent surgeon. It’s difficult to compete with specialties that offer a shorter training pathway or earlier independence. If it is difficult to attract young professionals into the speciality, then we need to make sure that those who do choose it become part of the EACTS community as early as possible. EACTS is attractive because of its global community and its educational opportunities. We need to involve the next generation in EACTS activities from the beginning of their careers, give them opportunities to participate and make sure they have a voice. We are already doing this, but I think we can do even more. What have you learned from the EACTS Presidents who came before you that you want to carry forward as we enter the Association's fifth decade? This is a very important question. I have maintained close contact with many of the previous Presidents, and some have become very good friends. I have learned something from each of them. One of the strongest messages I took from Franca Melfi's Presidential Address was the importance of being free from pressure and independent in your thinking, pursuing innovation and continuing to question yourself throughout your professional life. But independence does not mean working alone. You need to create a team environment so that everyone in the ward is connected. A team is something you create, but also something you maintain. And you always need to continue improving and innovating. Finally, how do you like to spend time and relax outside of work? Golf, when I have the time. Golf has brought some lessons into my professional life too. You must be humble – you won’t become a good golfer without that humility. When you are standing on the tee, you think strategically: what can I do that gives me the best chance of putting the ball in the hole? It teaches you to think about the situation in front of you and make the best decision you can – the same goes for surgery.

Robert Klautz did his surgical training at Erasmus Medical Center in Rotterdam. In 2002, he returned to Leiden as a staff surgeon at the Department of Cardiothoracic Surgery, where he became chair of the department and professor in 2008. Since 2019 he also works at the department of cardiothoracic surgery of Amsterdam University Medical Center, initially as chief of the department and later as professor.

His main clinical and research interests are in mitral and aortic valve reconstruction, alternative surgical strategies in heart failure treatment, and ischemia reperfusion injury. He has been the residency training director in Leiden and chair of the training committee of the Dutch Association of CardioThoracic Surgery. He serves as a member of the National Medical Disciplinary Board and has been member of several supervisory boards in the health care environment. He is an active member of the EACTS, STS, AATS and has recently served on the Joint Guideline Committee for Heart Valve Disease of the ESC and EACTS-

It is with great honour and pride that I accept the nomination for the role of Vice-President of the Council of EACTS. During my tenure on Council I hope to improve the mutual recognition of cardiothoracic certification in the European countries and in accordance with this the training of cardiothoracic surgeons. This would allow for better integration and exchange of knowledge of cardiothoracic surgery across

Europe and ultimately improve the outcome of the patients we treat. I realise this is a long term goal that will need many years to achieve but I hope to contribute and accelerate this process in the next few years.

Aortic Disease Domain

Aortic Disease Domain Chair Florian Schoenhoff hands over to Julia Dumfarth Julia is the perfect person to take over this position. She is especially suited as she has a broad experience in open cardiac surgery, as well as vascular and endovascular surgery. Julia is one of the few cardiac surgeons that continue to perform open thoraco-abdominal surgery. She is not only very well connected within our speciality, but also has a great standing with our colleagues in vascular surgery, cardiology and genetics.

Julia has been instrumental in bringing together multidisciplinary aortic teams, incorporating genetics in daily decision-making in- and outside of the operating room. I have no doubt that we will see a number of innovative and exciting projects being launched during her tenure as Aortic Disease Domain Chair.

Florian Schoenhoff

Julia Dumfarth

Past Aortic Disease Domain Chair

Aortic Disease Domain Chair

QUIP A NOTE FROM TREASURER JOSEPH BAVARIA To the EACTS community, It is a great honour to be nominated by the leadership, and elected by the membership, as the Treasurer of our European Association for CardioThoracic Surgery (EACTS). I am very excited and optimistic about the future of EACTS and

its ability to provide impact, value, and relevance to its members, constituents, stakeholders, and ultimately our patients, through better surgery. EACTS is a very sophisticated organisation with operations in various and numerous domains. We are now a much broader, larger, more impactful, and deeper Association than in the past and operate across the full spectrum of

EACTS Adult Cardiac Database The leading European database of adult cardiac surgery The EACTS Adult Cardiac Database (ACD) is a collaborative registry and benchmarking tool of cardiac surgical data for centres on an international scale, supporting the development of evidence-based guidelines to improve pre- and post-operative care, and advancing quality research. Based on real world data, the database enables the identification of best practice and promotes the importance of integrating quality improvement initiatives into daily clinical practices. The database is rapidly becoming an important resource for EACTS members looking to understand how their centre’s practice compares with those of an international peer group. Building a shared picture of cardiac surgery outcomes The ACD was established to gather high-quality clinical data from participating centres and turn it into useful insights for cardiac surgeons and their teams. By contributing data, centres can

Edgar Daeter

QUIP Committee Chair

Paola Quattroni QUIP Director

benchmark their outcomes against an international peer group and gain a clearer understanding of how their results compare across a wide range of surgical procedures. This creates an opportunity to move from data collection to action: using insights from the database to identify opportunities for quality improvement and, ultimately, support better outcomes for patients. The value of the ACD also grows as more centres participate. A broader dataset creates a stronger basis for international comparison and helps build a shared understanding of trends and outcomes in adult cardiac surgery. A major milestone for the ACD The ACD has surpassed a major milestone: 100,000 highly curated datasets from cardiac surgery procedures recorded from 14 countries, including: Belgium, Bulgaria, Estonia, Germany, Ireland, Italy, The Netherlands, Spain,

cardiothoracic surgery. EACTS offerings, in a broad sense, have literally doubled in the past 5 years. The Treasurer’s responsibility is to manage our assets so that EACTS is financially healthy and prosperous and is therefore able to provide the myriad services required to drive forward our specialty. This is the mission. I will dedicate my time and energy to Sweden, United Kingdom, Vietnam and others. In total, 51 hospitals have now signed up to the ACD, and the dataset continues to grow, along with the value it offers participating centres. This expanding international participation is an important part of the ACD’s strength. It enables centres to look beyond their localised institutional data and place their outcomes within a wider international context. Benchmarking is most valuable when it leads to meaningful questions and action. The ACD is designed to support this process by making complex clinical data more accessible and clear to interpret. By exploring trends and differences across procedures, teams can identify areas that might warrant closer examination and use the resulting insights to inform best practice. Robotic Database Extension The Adult Cardiac Database has officially expanded to now collect robotic surgery data in the Robotic Database Extension. This is a pioneer initiative bringing together data that until now was not available. Expert consensus has led to development of a new standard to be adopted globally. We welcome centres to join the initiative and submit data.

serve the membership and leadership of EACTS as we continue to expand our increasingly global Association to new and greater heights. It has been an honour to serve as the EACTS Treasurer for the past 3 years and I look forward to serving for one more term.

We believe the EACTS ACD will be the leading European database collecting cardiac data from around the world. More than a repository of data, the database is a powerful instrument for benchmarking and research. The EACTS ACD holds huge potential to identify areas of improvement in clinical practice, drive innovation and ultimately improve patient outcomes. Edgar Daeter, QUIP Committee Chair to join and submit data and benefit from using the EACTS ACD’s interactive tools to analyse cardiac surgical data and continually improve patient outcomes. EACTS members can set up an account and access the ACD via: www.eacts.org/quality-improvement/ adult-cardiac-database/

Contribute to the growing database Centres and national registries are encouraged Issue 3 Saturday 10 October 5

Trial Update Session — In Memoriam: Professor David Taggart 11:15 - 12:45

Room 115/116/117

FOCUS SESSION

EW N

12:00 – 12:45

AI for prediction and prevention of surgical complications

Mentorship Programme A brand-new initiative, the EACTS Mentorship Programme captures the experience and knowledge of our community, connecting professionals working across the full spectrum of cardiothoracic care. The Trial Update session returns this year with a programme focused on some of the latest developments and ongoing debates in cardiovascular medicine. Ahead of the session, we spoke to Secretary General Patrick about what is on the agenda and the importance of bringing colleagues together to examine new evidence and its implications for clinical practice. "This year’s Trial Update session will have particular significance as we remember Professor David Taggart, whose memorable intervention on EXCEL helped define this forum’s commitment to open, critical debate.

David reminded us that advancing patient care requires the courage to question how evidence is interpreted and presented. This morning, we will honour that legacy by examining new findings, challenging assumptions and debating some of the most pressing questions in our specialty, such as long-term results of NOBLE, the 5th universal definitions of myocardial infarction, emerging long-term results of the TAVI and SAVR trials showing long-term issues with TAVI, and finishing with a tribute by John Puskas to David Taggart and his legacy.

We’re looking for mentors! Help empower other cardiothoracic professionals to grow, succeed, and achieve their full potential. Share your expertise, support the next generation, and help drive our mission of advancing skills, surgery, and patient outcomes. Give back to the EACTS community and make a lasting impact.

Become an EACTS Mentor Register your interest today!

"I hope colleagues will join us to remember David and continue the rigorous, candid discussion he championed."

ROOM 111

Anna Minasyan

University Hospital of A Coruña, Spain

rtificial intelligence is increasingly being used to predict surgical complications, but understanding its potential requires looking beyond published performance metrics and into how these models actually work.

10:00 - 11:00

ROOM 113

Next-generation patch integrating autologous tissue ingrowth and structural extensibility endogenous tissue ingrowth. In the highpressure circulatory system, non-synchronous degradation creates micro-mechanical "blank zones"—spots where the polymer has degraded before host tissue has matured—leading to localized tearing, patch aneurysms, or catastrophic perforation. Shintaro Nemoto

Osaka Medical and Pharmaceutical University, Japan

F Why become a member of EACTS? As part of our global community, you’ll gain access to world-class resources, expert-led training and a network of professionals driving innovation in cardiothoracic surgery. Apply now to become a member of EACTS and enjoy access to all the below membership beneﬁts. Connect

Network with peers at the EACTS Annual Meeting – the leading global event in cardiothoracic surgery Access exclusive member-only rates for events COMING SOON: EACTS mentorship programme

Learn

Free access to the European Journal of Cardio-Thoracic Surgery (EJCTS) Reduced rates to contribute to the Interdisciplinary Cardiovascular and Thoracic Surgery journal (ICVTS) Free access to EACTS educational webinars Preferential rates for EACTS Academy training Apply for exclusive fellowships and bursaries

Advance

Join task forces and committees shaping surgical standards and practice Be part of initiatives supporting women, early-career clinicians and Allied Health Professionals Free access to the Adult Cardiac Database Apply for Outreach Grants Apply for Innovation Grants Vote at the General Assembly and help shape EACTS’ future.

Full active members pay just €300 a year. Visit the Membership Team on the EACTS Booth in the Exhibition Hall to ﬁnd out more or apply online here >>

eacts.org 6 EACTS DAILY NEWS

guarantee good AI models: clinical data must be accurate, representative, appropriately labeled and correctly preprocessed, while models must be designed to avoid problems such as overfitting. From there, I will move to the clinical question: can these mathematical models help us anticipate and prevent surgical complications? Surgical care generates heterogeneous and high-dimensional information, and machinelearning approaches can identify complex and nonlinear relationships between variables that may be difficult to capture with conventional approaches. Using examples from intra- and perioperative care, I will explore how AI can support risk

FOCUS SESSION

www.eacts.org

BECOME A MEMBER OF EACTS TODAY!

In this presentation, I will first take the audience “behind the scenes” of artificial intelligence. The central idea is simple: AI is not magic; it is mathematics. Using practical examples, I will explain how clinical variables become inputs to a machine-learning model, how datasets are prepared and divided for training and testing, and how algorithms learn patterns that can subsequently be used to make predictions. The discussion will include concepts such as neural networks, weights and biases, activation functions, loss functions, and gradient descent, presented from a clinician’s perspective rather than a computer scientist’s perspective. Data quality will be an important part of this discussion. Large datasets alone do not

prediction before surgery, recognize evolving risk during the procedure, and identify patients likely to deteriorate postoperatively. The emphasis will not only be on discrimination or AUC, but on what happens after a prediction is generated. The most clinically useful AI model is not simply the one that predicts complications accurately. Prediction becomes valuable when it gives clinicians enough time and information to change management and prevent that complication.

or decades, pediatric cardiac surgeons have pursued the ideal biomaterial for cardiovascular reconstruction—one capable of in situ tissue regeneration that adapts seamlessly to a child’s somatic growth without material deterioration. While conventional approaches have faced critical bottlenecks, a regulatory-approved hybrid technology now offers a pragmatic, engineering-driven solution to these longstanding bio-mechanical dilemmas, backed by outstanding clinical outcomes. The Pitfalls of Conventional Scaffold Technologies First-generation decellularized xeno-extracellular matrix (ECM) scaffolds initially showed promise. However, mid-to-long-term clinical data revealed a high propensity for chronic inflammation, accelerated calcification, and tissue thickening, frequently causing progressive stenosis or valvular dysfunction that required complex reoperations. To address these limitations, secondgeneration tissue scaffolds shifted toward 100% biodegradable synthetic polymers fabricated via electrospinning. While eliminating antigenic risks, they introduce a fragile mechanical dilemma: the degradation rate must perfectly synchronize with

THANK YOU!

The Hybrid Strategy: Over 300 Pediatric Cases and Proven Efficacy Enter a next-generation surgical patch developed by a Japanese academia-industry consortium led by Osaka Medical and Pharmaceutical University. Rather than chasing the ideological ideal of 100% biodegradation, the developers adopted a physics-driven hybrid strategy. The new patch features a highly sophisticated warp-knitted fabric combining biodegradable poly-L-lactic acid (PLLA) and non-biodegradable polyethylene terephthalate (PET) yarns, completely sealed with a cross-linked gelatin membrane. Initially, the PLLA/PET framework handles the full hemodynamic load with optimal flexibility. Over six months, as the gelatin resorbs, host cells infiltrate the matrix, transforming the patch into a living, endothelialized autologous tissue. Crucially, once the PLLA disappears, the remaining permanent PET skeleton transitions into a unique sliding loop configuration. This allows the fabric, along with matured autologous tissue, to physically expand in response to the mechanical tension of the child’s growing blood vessels or balloon-catheter expansion. Moving beyond experimental models, this prestigious, award-winning innovation— recognized by multiple high-profile accolades from the Japanese government and major chemical industry associations—has achieved remarkable clinical success. It has received Japan regulatory approval and has already been successfully utilized in over 300 pediatric cases

Structure of the Hybrid knit inducing autologous tissue ingrowth

across Japan (Synfolium®, Teijin Medical Technologies Co., Ltd., Osaka, Japan). While this presentation focuses primarily on the basic science and innovation underlying the patch’s structural design and geometric textile engineering, its clinical translation has yielded overwhelmingly superior performance.

advanced engineering with proven clinical longevity. References 1.

Nemoto, S., Konishi, H., Shimada, R., Suzuki, T., Katsumata, T., Yamada, H., Sakurai, J., Sakamoto, Y., Kohno, K., Onishi, A. and Ito, M. (2018) ‘In situ tissue regeneration using a warp-knitted fabric in the canine aorta and inferior vena cava’, European Journal of Cardio-Thoracic Surgery, 54(2), pp. 318-327. doi:10.1093/ejcts/ezy045. 2. Nemoto, S., Konishi, H., Suzuki, T., Shimada, R., Katsumata, T., Osawa, S. and Yamaguchi, A. (2021) ‘Long-term viability and extensibility of an in situ regenerated canine aortic wall using hybrid warp-knitted fabric’, Interactive Cardiovascular and Thoracic Surgery, 33(2), pp. 165-172. doi:10.1093/icvts/ivab064. 3. Kasahara, S., Yoshimura, Y., Ichikawa, H., Hirata, Y., Murayama, H., Nakano, T., Miura, M. and Nemoto, S. (2024) ‘Early clinical results for a new self-organizing hybrid fabric in congenital cardiac surgery’,

Representative intraoperative photo of the patch implanted in

Annals of Thoracic Surgery Short Reports, 2(4), pp.

right ventricular outflow (from Ref [3])

Concurrently at this EACTS Annual Meeting, long-term clinical data demonstrating its exceptional 5-year efficacy and safety will be presented in a dedicated clinical session. By successfully preventing both the tissue degeneration of xeno-ECMs and the mechanical instability of 100% biodegradable polymers, the new hybrid patch delivers a true paradigm shift in in situ tissue restoration, beautifully bridging

804-809. doi:10.1016/j.atssr.2024.04.020. 4.

Arabkhani, B., Nemoto, S., De Kerchove, L., Perier, P., Wilbring, M., Sarikouch, S., Bertelli, F., Hjortnaes, J., Heinisch, P.P., Casselman, F., Beyersdorf, F., Hazekamp, M. and De Paulis, R. (2026) ‘The EACTS Innovation Committee’s perspective on the “Heart Valve of the Future”’, European Journal of Cardio-Thoracic Surgery, 68(6), ezag185. doi:10.1093/ejcts/ezag185./ezy045.

With grateful thanks to the members of the Executive Programme Committee who have worked tirelessly to shape this year’s EACTS Annual Meeting. Korkut Bostanci Gloria Färber Edoardo Zancanaro Milan Milojevic Patrick Myers

Rafael Sádaba Florian Schoenhoff Vladimiro Vida Alicja Zientara

Working alongside the Events Team:

Sharon Pidgeon Amanda Cameron Katie Bingham

Jenise Chisholm Marina Gueli

Issue 3 Saturday 10 October 7

CONNECTING THE CARDIOVASCULAR COMMUNITY Cardiovascular News is the leading source of news and information for specialists in cardiovascular care.

3 Top trials

10 Legacy

Practice-changing trials from a packed conference schedule

EUGENE BRAUNW The father of modern ALD cardiology remembere d

FULL-PAGE ADVERT

- NEWS - COMMENT - INDUSTRY UPDATES

12 Profile

www.cardiovascularn

BERNARDO CORTE SE Founder of DCB Academ discusses coronary adv y ances

0.81

NEW FORMAT

■ MAY 2026 | Issue

Beyond the wire

Latest-generation physiology technologies show promise for guiding PCI

Full story on page 14

FIND OUT MORE AT BIBAPUBLISHING.COM/SUB/CN-SUB.HTML

ews.com

FRANCIS FONTAN FUND FELLOWSHIPS Thoracic & Minimally Invasive Surgery Fellowship Victor Manuel Sanchez Sotelo Instituto Mexicano del Seguro Social, Mexico

s a board-certified cardiothoracic surgeon from Mexico, my primary motivation for applying for the EACTS FFF Thoracic and Minimally Invasive Surgery Fellowship was to deepen my expertise in advanced minimally invasive techniques and surgical innovation. I pursued training at a world-leading center for thoracic surgery so that I could acquire the necessary skills and translate these practices directly to the Mexican population. Shanghai Chest Hospital offered the ideal environment for this pursuit. From my first day in Shanghai, the scale and efficiency of the clinical operations were extraordinary. Shanghai Chest Hospital performs approximately 120 thoracic procedures daily, with our surgical team routinely completing over 17 cases per day. This ultra-high volume provided the perfect setting to observe and participate in complex procedures across the full spectrum of thoracic oncology—including lung, mediastinal, tracheal, chest wall, and esophageal conditions. Beyond standard anatomical resections, I gained extensive exposure to complex Uniportal VATS (UVATS) and Robotic-Assisted Thoracic Surgery (RATS), including sleeve resections, carinal reconstructions, and intricate subsegmentectomies. A key highlight of my fellowship was the direct integration of surgical technology and translational research into daily clinical practice. Complementing our operating room activity, the hospital’s surgical simulation and education center provided a platform to refine technical skills and master complex maneuvers in Uniportal VATS and robotic surgery. In the clinical setting, I took responsibility for pre-operative 3D CT reconstructions and surgical margin planning, as well as intraoperative Augmented Reality (AR) nodule

localization. Being actively involved in our team’s clinical research such as comparing AR-guided localization against traditional CT-guided or developing workflow for nodule identification using all these tools. These methods provided firsthand insight into how technology enhances surgical precision. Furthermore, I participated in collaborative meetings with software engineers working on AI-driven surgical tools and had the privilege of engaging with the patient-derived organoid laboratory, exploring advanced translational platforms for personalized oncology. The academic environment was equally enriching. I engaged in daily multidisciplinary case discussions focused on complex thoracic oncology. During my stay, I presented as a speaker at the "Shanghai Chest Symposium on Thoracic Surgery" and shared case report discussions at the "Thoracic Horizons – China/USA Thoracic Surgery Academic Forum." Academic exchange extended beyond our hospital through joint journal clubs at Shanghai East Hospital alongside Dr. Wentao Fang and his team. Throughout the fellowship, my mentor, Dr. Cheng Xinghua, provided strong guidance, encouraging my attendance at the World Congress on Lung Cancer (WCLC) in Seoul, Korea, and supporting my attainment of formal certifications in Uniportal VATS and robotic surgery.

Weill Cornell Medicine, USA

irst and foremost, my sincere thanks go to the Francis Fontan Fund and EACTS for giving me the opportunity to undertake the Pragmatic Clinical Trials Fellowship at Weill Cornell Medicine in New York. As a fifth-year cardiac surgery resident at Inselspital Bern, I came to the fellowship with a clear goal: to become a more independent clinical researcher and acquire the methodological skills needed to develop and lead clinical research projects myself. Now, only two months into the two-year fellowship, I have already had the opportunity to approach research from an entirely new perspective. An integral part of this training is the MSc in Clinical Epidemiology and Health Services Research at Weill Cornell, which provides the fellowship’s theoretical foundation. Beginning with an intensive summer program, the MSc covers epidemiology, study and trial design, statistics and coding, literature searches, and scientific writing in small classes. The summer course lives up to the word “intensive” homework included - and provides an excellent foundation for our projects. Regular feedback sessions allow us to apply what we learn directly to ongoing research. The MSc and fellowship interlock remarkably well.

I am deeply grateful to the European Association for CardioThoracic Surgery (EACTS) and the Francis Fontan Fund for making this transformative experience possible. My most sincere gratitude goes to my mentor, Dr. Cheng Xinghua, whose outstanding leadership and surgical mastery have been a true source of inspiration to me. I am also profoundly thankful to his entire surgical team, who welcomed me with open arms and treated me like a brother throughout my stay. Finally, my heartfelt gratitude goes to my wife, whose unwavering support and companionship made this international journey achievable.

This fellowship has significantly expanded my technical repertoire, decision-making skills, and perspective on modern thoracic surgical oncology. The combination of ultra-high surgical volume, technological innovation, and academic rigor has equipped me with

Pragmatic Clinical Trials Fellowship in partnership with Weill Cornell Medicine Kai Münker

invaluable expertise that I am eager to apply directly to my practice in Mexico, elevating surgical standards for our patient population.

Before coming to New York, my research experience included a basic science doctoral thesis, predominantly retrospective clinical studies, and the development of a local prospective pilot trial. However, my research had often depended on others for methodological and statistical components. I wanted to change that. My goal was to learn how to develop meaningful research questions, design studies and clinical trials, perform statistical analyses, and bring a project from an initial idea to publication. Put less formally, I wanted to become “the guy to ask” when it comes to research. Working across the research process has substantially deepened my understanding of concepts I had previously only begun to grasp. In particular, systematic reviews and meta-analyses have gone from concepts I was familiar with to methods I now understand on a much more fundamental level. Just as importantly, the epidemiology training has changed how I read the literature. Learning to critically assess not only results, but also methodology and applicability provides a different perspective on published evidence and, in

turn, helps generate better research questions. The practical side of the fellowship takes place within Professor Mario Gaudino’s group at Weill Cornell. Professor Gaudino is one of the most academically accomplished cardiac surgeons in the field, and the opportunity to learn from him and his team was a major reason I came to New York. My daily work combines developing my own projects with contributing to larger clinical trials. Another major strength is the opportunity to contribute to a broad range of research projects, with the prospect of publishing extensively throughout the fellowship. Whenever questions arise, there is expertise within the team to draw upon - in methodology, statistics, or the practicalities of clinical research. One of the most striking lessons during these first two months has been seeing the apparatus required to make large pragmatic trials work. Successful trials depend on a well-oiled research

infrastructure and substantial persistence. Fortunately, this trait is present in most cardiac surgeons in my experience. Mentorship is essential to this process. Professor Gaudino has the ability to explain both the bigger picture and the details behind methodological decisions, while demonstrating exceptional rigour in his own work. Members of the wider team contribute their individual expertise. One of the most rewarding experiences is developing my own projects, discussing them with experts, and knowing that the resulting study will be stronger because of that process. Over the coming two years, I hope the fellowship will also provide the foundation for lasting international collaborations. When I return to Europe, I want to lead clinical research projects, contribute to pragmatic clinical trials, and support younger colleagues with their own research. Cardiac surgery is changing rapidly. Advances in interventional cardiology, robotics and minimally invasive surgery, and artificial intelligence will continue to challenge established practice. We need high-quality evidence to determine which innovations actually improve patient care, and pragmatic clinical trials offer an important way of answering these questions in real-world practice. For cardiac surgeons with similar academic aspirations, I can strongly recommend the Francis Fontan Fund Pragmatic Clinical Trials Fellowship.

Issue 3 Saturday 10 October 9

FOCUS SESSION

Rendezvous approach for posterior mediastinal dumbbell tumors

Hussein Elkhayat

Chest Wall and Thoracic Trauma Task Force Chair

osterior mediastinal dumbbell tumours present an unusual surgical problem. Extending from the chest towards or into the spinal canal, they sit at the interface of thoracic and spinal surgery. Rather than approaching these tumours in separate stages, our teams developed a “rendezvous” strategy to address both components during the same operation. At the 2026 EACTS Annual Meeting, we presented six years of experience with this

technique in 29 patients. The thoracic component was approached by VATS or thoracotomy, while the spinal team used a separate posterior approach for intraspinal tumour disconnection and resection, with vertebral fixation when required. Both components were addressed during a single anaesthetic. Mean operative time was 3.3 hours and mean hospital stay 5.2 days, with no new neurological deficits observed on the first postoperative day.

became more standardized as the workflow between the thoracic and spinal teams developed. Our experience suggests that the rendezvous approach is not simply a technical modification, but a multidisciplinary strategy for tailoring complex surgery to the anatomy of the individual tumour.

The main finding from our series is that this combined thoracic–spinal strategy allowed these complex tumours to be managed within a single operative setting, with acceptable perioperative outcomes and surgical exposure tailored to the individual tumour rather than a fixed approach. We also observed an important learning effect. After approximately 10 cases, operative performance became more consistent. Rather than simply becoming faster, the procedure

Introducing Pulse by EACTS

Pulse brings EACTS media content together in one engaging, easy-tonavigate platform, making it simpler than ever for members to discover and enjoy our content on demand. I encourage every member to explore Pulse and make full use of this exciting new member benefit throughout the year.

Patrick Myers Secretary General

EACTSNews Hub

Read the latest news from EACTS on our regularly updated website News Hub.

Visit the eacts.org homepage for the latest features, or find us

under the ‘Our Community’ tab. 10 EACTS DAILY NEWS

Supporting Partner Issue 3 Saturday 10 October 11

Nursing and Allied Health Professionals in cardiothoracic surgery 10:00-11:00

ROOM 131-132

Cristina Ruiz Segria James Cook University Hospital, Edinburgh

As EACTS marks four decades of advancing cardiothoracic surgery, this year's Nursing and Allied Health Professionals (AHP) programme reflects on the evolution of nursing and allied health roles alongside the speciality itself. With multidisciplinary working, technological innovation and patient-centred care becoming increasingly important, the sessions will explore how these professions continue to shape the future of surgical care. The EACTS 40th anniversary celebration is a chance to understand how our roles and scope

of practice have evolved and how we are a crucial part of EACTS. Our Committee is growing, and it's important that we're part of those celebrations. The significant changes and rapid advances in robotics and minimally invasive surgeries have transformed how operations are performed - and how crucial it is now to have key members of medical teams working together to improve patient outcomes with safe, high-quality care. Multidisciplinary working has never been more important. Teams are the way forward in surgery, with new technologies, we need to work as one. Patients want to recover fast, go home early and live their lives, so they need a team that can ensure the surgery, preparation and aftercare is a success. Today, the Nurses and Allied Health Professionals session will take a look at the evolution and challenges of advanced roles in the field of cardiothoracic surgery and how they have changed in the last 40 years around the world. The session will have Committee Members Melanie Freas and Professor Blibleraj, and feature nurse Laura Saksa from the Cleveland Clinic, USA, examining the importance of striving for patients after any corrective surgery of the sternum to recover well and fast, and go home from day one. The programme will also highlight the growing importance of patient education, helping patients and their families better understand the surgical journey while supporting improved recovery and empowering them to play an active role in their care.

The abstract session is a chance for allied healthcare professionals to connect with peers. It will showcase new projects from across the AHP community and include a real patient perspective on participating in clinical research. We know our research is important, but we also want to hear patients’ perspectives. They are part of the change. Collaboration extends beyond the lecture theatre, and this year's programme will also introduce its first dedicated Nurses and Allied Health Professionals breakfast. Taking place before the scientific sessions begin, the event will provide an informal opportunity for delegates to meet colleagues over coffee. Just turn up, on a first come, first serve basis. The Committee's commitment to education continues throughout the year with dedicated projects and webinars, alongside the EACTS Nursing and Allied Health Professionals Fellowship, now in its second year. The Fellowship gives Nurses and Allied Health Professionals the opportunity to visit another centre, experience different ways of working, learn from colleagues in another country and bring new knowledge and ideas back to their own institutions. Applications will open on 1st March 2027 for Fellowships taking place in 2028. As the Committee continues to grow, I hope delegates from every part of the cardiothoracic community will use the opportunity to take part and engage with the

This fellowship broadened my international perspective, fostered global nursing collaboration, and empowered me to contribute meaningfully to the development of nursing research and the professional profile of cardiac surgery nursing in Austria. Karin Hinterbuchner, Past Fellow

programme and celebrate the progress of our profession and contribute to shaping its future. Everybody is welcome at the EACTS Annual Meeting. It's an international conference with innovative people who want to contribute to shaping the future of cardiothoracic care.

We want to learn what's happening around the globe, collaborate, educate each other and be inspired by the amazing things people are working on.

CVCC Level 1 & 2 Examination – Updated Regulations! Easier than ever to apply, view our updated regulations. The Critical Care Certification is for surgeons who are recognised as leaders of multidisciplinary, high performing teams. The Membership of the European Board of Cardiothoracic Surgery (MEBCTS) is for surgeons at the end of national training who are ready to work independently.

FEBCTS Level 2 Examination

ROOM 212

Donation After Circulatory Death and Its Impact on the Future of Heart Transplantation How DCD Managed to Change Heart Transplantation in Switzerland major milestone. But this was never simply about introducing a machine. It required a completely new clinical pathway involving intensive care teams, donation coordinators, anesthesiologists, perfusionists, transplant surgeons, cardiac surgeons and transplant cardiologists. Close cooperation between the Swiss transplant centers in Zurich, Bern and Lausanne was David Reineke University Hospital of essential. Bern, Switzerland The impact is reflected in the numbers. Before the DCD era, Switzerland performed approximately 30–40 heart transplants annually across three centers, with long waiting lists. eart transplantation has always faced one fundamental limitation: there are not Today, transplant activity and access to donor organs have reached levels that would have enough donor hearts for the patients who need them. For decades, transplantation seemed almost unimaginable for such a small country. In fact, between 2022 and 2024, the relied predominantly on donation after brain death (DBD), leaving many potential donors— probability of receiving a transplant increased and many potentially transplantable hearts— significantly, with a reported hazard ratio of 1.84 (1). outside the donor pool. The introduction of donation after circulatory death (DCD), DCD was a key driver, but not the only one. together with normothermic regional Switzerland has witnessed several almost perfusion and ex-vivo heart perfusion, has simultaneous developments: the transition fundamentally changed this paradigm. In toward an opt-out model of organ donation, Switzerland, these developments have gone increasing public awareness, DCD hand in hand with a series of innovations that implementation, rapid procurement, ex-vivo together have brought heart transplantation perfusion with the Organ Care System (OCS), to what we might call “Heart Transplantation broader acceptance of extended donor criteria, 2.0.” and international cooperation enabling longdistance DBD procurement. Together, these DCD itself is not new to Switzerland. It was developments have expanded both the donor introduced as early as 1985 but discontinued pool and the geographical reach of because of legal uncertainties. After the transplantation. Hearts that previously would regulatory framework was clarified, DCD was have been declined because of donor age, gradually reintroduced. logistics, ischemic time or complex donorThe real breakthrough for heart recipient constellations can now increasingly be transplantation, however, came with technologies considered. capable of recovering, preserving, resuscitating Ex-vivo perfusion has also fundamentally and assessing a heart after circulatory arrest. changed the philosophy of organ preservation. The introduction of ex-vivo heart perfusion in Instead of simply storing an organ on ice, the Switzerland in 2022 and the first Swiss DCD heart can be maintained in a warm, beating heart transplantation in March 2023 marked a state, allowing its function and metabolic

Critical Care Examination Applications opening 15th October!

MEBCTS Level 1 Examination

FOCUS SESSION 10:00 – 11:00

EUROPEAN BOARD OF CARDIOTHORACIC SURGERY

The Fellowship of the European Board of Cardiothoracic Surgery (FEBCTS) is for surgeons who are already practicing independently.

It has been an immense honour and privilege to serve as Chairman of EBCTS for the last 6 years and on the Board for 8 years. I am deeply grateful to the many colleagues, examiners and candidates whose professionalism and commitment have enabled us to modernise our examinations, deliver them successfully (even throughout the COVID pandemic), establish the Unified European Board of Thoracic Surgery, and introduce the world’s first critical-care examination specifically for cardiac surgeons. Now as an Emeritus Examiner, I will remain involved in quality-assurance work and in exploring how artificial intelligence can be leveraged in examinationrelated tasks. I am enormously proud of all that we have achieved together and delighted to see the Board flourishing, with record candidate numbers and a very exciting future ahead. Stephen Clark on stepping down as EBCTS Chair

Visit our website ebcts.org for more information

12 EACTS DAILY NEWS

recovery to be assessed. Preservation has become active organ assessment and, in the future, potentially organ rehabilitation. Our own clinical practice is evolving further. Following the implementation and consolidation of DCD and ex-vivo perfusion, we have optimized procurement and transplantation according to emerging evidence. With beatingheart implantation after ex-vivo perfusion (2), a second cardioplegic arrest can be avoided, potentially reducing ischemic injury and the need for postoperative mechanical support. More recently, based on promising preliminary data (3), we have explored an even more radical concept: avoiding cardioplegia altogether during procurement and transferring the heart directly to the perfusion system. Despite prolonged warm ischemia, the heart frequently resumes beating immediately, often without defibrillation or pacing, and demonstrates expected lactate profiles.

These observations raise an intriguing question: have we overestimated the protective role of cardioplegia in the setting of ex-vivo perfusion? They also suggest that warm ischemia may affect the heart differently inside and outside the donor body. Switzerland has shown what is possible when legislation, public engagement, technology, national collaboration and clinical innovation move together. DCD was the catalyst. The result is a new landscape of transplantation with one clear objective: to make more hearts available to more patients, and to give them the chance of a longer and better life. Figure 1. Source Swiss transplant

REGISTRATION IS OPEN!

References Source: Swiss transplant doi:10.1001/jamanetworkopen.2024.1828 doi:10.1016/j.xjtc.2025.03.013

Issue 3 Saturday 10 October 13

SCIENTIFIC PROGRAMME

FOCUS SESSION

Prognostic determinants in atrial secondary MR and TR: moving beyond the valve Acquired Cardiac Disease Domain

Aortic Disease Domain

Thoracic Disease Domain

General Interest

Congenital Disease Domain

SATURDAY 10 OCTOBER

Victoria Delgado

Room 115/116/117

Room 111

Room 112

Room 113

Room 114

Room 120-121

Room 131-132

Room 211

Room 212

08:30 – 09 :30

Aortic valve repair without root aneurysm – Video session

When surgeon and machines collaborate - AI tools every surgeon should know

Beyond repair: Mastering mitral valve replacement

Nightmares of thoracic surgery

Post-operative management of Type A dissection – The importance of multidisciplinary teams in the treatment of acute dissection

EACTS Rising researchers session 2

Congenital rapid response 2

Back to the future

09:30 – 10:00 Moderated e-Posters, e-Posters Theatres 1, 2, 3 and 4 10:00 – 11:00 Improving CABG outcomes in the OR

10:00 – 11:00 Remodel, resect, or replace? – How best to treat the severely emphysematous lung

10:00 – 11:00

Endovascular repair in Heritable Thoracic Aortic Disease – Do as much nothing as possible or pushing the limits?

Basic Science and innovation for congenital heart disease

11:15 – 12:15

11:15 – 12:45 Trial update session

10:00 – 11:00

Airway sparing surgery 12:00 – 12:45 Artificial Intelligence in thoracic surgery

10:00 – 11:00

ranscatheter therapies T in clinical action: Real‑world cases that sharpen decision‑making

Nursing and allied health professionals in cardiothoracic surgery

Contemporary challenges and innovations in minimally invasive valve and atrial fibrillation surgery

The changing landscape of heart transplantation

10:00 – 11:00 Commandos / VSD

11:15 – 12:15

11:15 – 11:45

Special session dedicated to J.V. Comas on transposition of the great arteries

Abstract session – Nursing and allied health professionals

12:45 – 13:30 Closing Plenary, Room 115/116/117 EACTS Awards Ceremony Farewell Drinks Reception from 13:30, Entrance Hall

For detailed programme and break times please refer to the EACTS App.

Learning Labs

Your guide to what's on

TUNE IN

Watch live and recorded content from this year's Annual Meeting on EACTS TV. Educational and entertaining, EACTS TV features compelling panel debates, Annual Meeting highlights and interviews with the world’s leading cardiothoracic surgeons.

EACTS LEARNING LAB SCHEDULE Saturday 10 October

Location

Time

Session

Panelists

09:00 – 10:00

Learning Lab – Touch the valves

EACTS Learning Lab 1

09:30–09:45

Your daily briefing: Saturday

Florian Schoenhoff Korkut Bostanci Emily Pan

09:00 – 11:00

Endoscopic Dry Lab Training - Basic, Mitral & Aortic

EACTS Learning Lab 2

10:30–10:45

Annual Meeting highlights & looking forward to 2027

Patrick Myers Lorenzo Galletti

10.00-10:15

Better Data, Better Outcomes: How Quality Improvement Is Changing Cardiac Surgery

Paola Quattroni Edgar Daeter Duncan Ingram

Enjoy even more science at the 40th EACTS Annual Meeting

SATURDAY 10 OCTOBER Time

09:30-10:00

References 1.

Saito Y, et al. Atrial functional mitral regurgitation: prevalence, characteristics and outcomes from the National Echo Database of Australia. Open Heart. 2023;10:e002330. Kagiyama N, et al. Outcomes and predictors of cardiac events in medically treated patients with atrial functional mitral regurgitation. Echocardiography. 2020;37:1131–1138. Atrial Functional Mitral Regurgitation: The Natural History of Atrial Functional Mitral Regurgitation. J Am Coll Cardiol. 2024;83. Fava AM, et al. Atrial Functional Tricuspid Regurgitation: Contemporary Characteristics, Outcomes, and Novel Risk Score. JACC Advances. 2025;4:101623. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025;46:4635–4736.

Contemporary outcomes of tricuspid valve surgery: a nationwide multi-centre analysis of primary and reoperative surgery

LEARNING LABS

e-POSTERS

right atrial remodelling, RV–pulmonary artery coupling and evidence of systemic congestion. These observations have practical implications. The 2025 ESC/EACTS Guidelines explicitly distinguish atrial from ventricular secondary MR and emphasise identification and treatment of underlying AF and HFpEF. For suitable patients with severe atrial SMR, surgery has gained a stronger role, while transcatheter edge-to-edge repair may be considered in selected high-risk patients.⁵ For TR, the guidelines similarly emphasise early assessment, including RV function and pulmonary pressures, reflecting growing recognition that intervention may become more hazardous once advanced right-heart failure and end-organ dysfunction are established.⁵ The key question, therefore, is not simply “How severe is the MR or TR?” but rather “What is the biological stage of the atrial valve disease?”. Atrial size and function, rhythm status, ventricular performance, pulmonary pressures, right-heart reserve, congestion and comorbidities may all provide prognostic information that complements conventional measures of regurgitation. As our understanding evolves, prediction may ultimately allow intervention to move from a response to advanced valve disease towards prevention of irreversible cardiac remodelling. The challenge for the coming years will be to define robust, validated markers that identify the window in which treating the valve - and the atrial disease driving it - can meaningfully change outcomes.

RAPID RESPONSE

Jules Olsthoorn

Isala Heart Centre, The Netherlands

SATURDAY 10 OCTOBER

DOWNLOAD THE EACTS APP HERE

trial secondary mitral regurgitation (ASMR) and atrial functional tricuspid regurgitation (AFTR) are increasingly recognised as distinct phenotypes of secondary valve disease. Their common denominator is atrial remodelling: enlargement of the left or right atrium and subsequent annular dilatation can produce significant regurgitation, often in the setting of atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF). Yet the prognostic significance of these lesions cannot be understood by looking at valve severity alone.

This is particularly relevant to the session “Atrial secondary MR and TR: Predict, rethink, intervene?”. The challenge is to identify which patients are likely to progress, which are already developing adverse cardiac consequences, and when intervention might alter the disease trajectory. For ASMR, the evidence suggests that the atrium is only part of the story. Large observational cohorts have demonstrated that patients with atrial functional MR are typically

Keynote Lecture – Toni Nadal: Everything can be trained

EACTS TV

Leiden University Medical Center, The Netherlands

older and have a high prevalence of AF. In the National Echocardiographic Database of Australia, AFMR accounted for approximately 40% of moderate or severe functional MR. Although outcomes were more favourable than in ventricular functional MR after adjustment, mortality remained substantial, with age, pulmonary hypertension, AF and reduced LV ejection fraction among important determinants of outcome.¹ Other studies reinforce the importance of the patient's overall phenotype. In medically treated patients with atrial functional MR, severe MR, symptoms, LV dilatation and comorbidity burden were independently associated with adverse cardiac events.² Conversely, recent work examining the natural history of AFMR found that progression of MR itself was relatively uncommon and was not independently associated with mortality. Instead, age, concentric LV remodelling, impaired diastolic function and elevated pulmonary pressures were more closely associated with mortality.³ This challenges a purely valve-centred approach and highlights the importance of understanding the atrial, ventricular and haemodynamic substrate. AFTR presents a similar paradigm, but with the additional importance of right-heart reserve. In a contemporary cohort of 370 patients with significant AFTR, right-heart failure, increased right atrial volume, reduced TAPSE/RVSP ratio, low serum albumin and greater TR effective regurgitant orifice area were independently associated with one-year mortality.⁴ These findings suggest that prognostic assessment should encompass not only TR severity but also

Topic

Location

Acquired Cardiac – Mitral Valve

e-Poster Theatre 1

Aortic Domain 5

e-Poster Theatre 2

Congenital Domain 5

e-Poster Theatre 3

Thoracic Domain 5

e-Poster Theatre 4

he tricuspid valve has long been the "forgotten valve" and its reputation has shaped practice: historical series reported in-hospital mortality of up to 10% for isolated surgery and as high as 37% for reoperations [1–3]. The result has been under-treatment and late referral, even though more-than-moderate tricuspid regurgitation affects around 4% of people over 75 and independently predicts mortality and right heart failure when untreated [4,5]. s. This presentation asks whether those figures still describe contemporary practice. Using the Netherlands Heart Registration (NHR), the nationwide quality registry covering all 15 Dutch cardiothoracic centres, we analysed two cohorts: 599 patients undergoing primary tricuspid valve surgery (2007–2021) and 345 undergoing tricuspid surgery as a reoperation after previous cardiac surgery (2007–2023). Concomitant aortic, aortic-valve and mitral procedures were excluded, so the tricuspid valve was the primary target in every case. In primary tricuspid valve surgery, repair was performed in 82% of patients. Thirty-day mortality was 4.0% overall and 2.8% once two high-risk subgroups, active endocarditis (8.5%) and

concomitant CABG (20.9%), were set aside. Respectively, 120-day mortality was 7.8% and 6.3%. Five-year survival was 72.0% overall and 74.8% in patients without endocarditis or CABG. Complications were infrequent, with new-onset arrhythmia the most common (21.7%). The reoperative cohort was a higher-risk population: median EuroSCORE II was 5.6% and 8.1% of patients were in critical preoperative condition. Even so, 30-day mortality was 4.3%, 120-day mortality 8.1% and five-year survival 67.8%, with repair still achievable in 64% of cases. These figures sit close to those of primary surgery and compare favourably with the 14.6% early mortality of one of the few contemporary reoperative series [3]. To our knowledge, this is the first nationwide analysis to report five-year survival after reoperative tricuspid surgery. Mortality showed no downward trend over time in either cohort; annual rates fluctuated between 0–10% for primary surgery and 0–16.7% for reoperations. The likely explanation is volume: nationwide, only 30–40 primary and 15–20 reoperative procedures are performed each year, roughly one to three cases per centre. This raises a legitimate question about centralisation. Second, the favourable outcomes almost certainly reflect careful patient selection and increasingly, diversion of the highest-risk patients to transcatheter therapies, which rose from a single NHR case in 2016 to more than 50 in 2021. Key findings Contemporary tricuspid valve surgery, primary or reoperative, is not the high-mortality procedure the historical literature describes: early mortality is around 4%, and under 3% in selected primary cases. Previous cardiac surgery alone should not be a reason to

withhold tricuspid intervention; reoperative outcomes approach those of primary surgery. Low per-centre volumes and no temporal improvement in mortality argue for centralising this surgery. These nationwide figures are a real-world surgical benchmark against which transcatheter tricuspid therapies should be judged.

References • Scotti, A., Sturla, M., Granada, J.F. et al. (2022) ‘Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies’, EuroIntervention, 18, pp. 840–851. • Staab, M.E., Nishimura, R.A. and Dearani, J.A. (1999) ‘Isolated tricuspid valve surgery for severe tricuspid regurgitation following prior left heart valve surgery: analysis of outcome in 34 patients’, Journal of Heart Valve Disease, 8, pp. 567–574. • Pfannmüller, B., Moz, M., Misfeld, M. et al. (2013) ‘Isolated tricuspid valve surgery in patients with previous cardiac surgery’, Journal of Thoracic and Cardiovascular Surgery, 146, pp. 841–847. • Topilsky, Y., Maltais, S., Medina Inojosa, J. et al. (2019) ‘Burden of tricuspid regurgitation in patients diagnosed in the community setting’, JACC: Cardiovascular Imaging, 12, pp. 433–442. • Topilsky, Y., Nkomo, V.T., Vatury, O. et al. (2014) ‘Clinical outcome of isolated tricuspid regurgitation’, JACC: Cardiovascular Imaging, 7, pp. 1185–1194. • Dreyfus, J., Audureau, E., Bohbot, Y. et al. (2022) ‘TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery’, European Heart Journal, 43, pp. 654–66

VIEW THE MODERATED e-POSTERS 14 EACTS DAILY NEWS

Issue 3 Saturday 10 October 15

EXHIBITION FLOOR PLAN

EXHIBITION OPENING TIMES: Thursday 8 October Welcome Reception Friday 9 October Saturday 10 October

09:00 - 18:30 17:00 - 18:30 09:00 - 17:00 09:00 - 12:00

his year's exhibition marks a special milestone as EACTS celebrates

We are equally delighted to welcome new exhibitors joining us this year and

40 years of advancing cardiothoracic surgery. Over four decades,

look forward to building new relationships as we embark on the next chapter of

the Annual Meeting has grown into a truly global event, bringing

collaboration, innovation and progress together.

together delegates from more than 100 countries and showcasing the

168 22

latest innovations from industry partners across the world.

167

147

148

150

137

138

EACTS LEARNING LABS

139

136

135

127

128

129

130

117

152

116

159

153

160

154

161

162

30 116

TV STUDIO 78

115

100

102

108

34 35

107

CATERING POINT

94 80

106 105

EACTS

155

83 157

E- POSTER AREA 3

163 165

103

166

47 E- POSTER AREA 1

169 170 171 172

E- POSTER AREA 4

16 EACTS DAILY NEWS

perfect space to take a break from the busy programme, connect with

journey. Their longstanding partnership has played a vital role in the success

colleagues and enjoy a friendly challenge between sessions.

E- POSTER AREA 2

173

NETWORKING AREA

Stand Number

Exhibitor Company Name

Stand Number

168

Jafron Biomedical

163

Abacus Medicine Pharmaceuticals

JenaValve Technology

155

ABBOTT

Johnson & Johnson MedTech | Heart Recovery

ADCORPUS

165

Johnson & Johnson MedTech Surgery

157

Advanced Medical Solutions

116

KLS Martin Group

Advanced Medtech Solutions

LivaNova

ADVITOS

LSI Solutions

139

Andocor

Medela AG

117

Ansabere Surgical

152

Medistim ASA

Arthrex GmbH

115

Medtronic

Artivion, Inc.

MedXpert

AtriCure

Meril Life Sciences

150

Avenns Medical

108

METRUM CRYOFLEX

107

Baxter International

Miconvey Technologies

161

Beijing Bohaikangyuan Medical Devices

MicroPort® Surgical

148

BioCer Entwicklungs-GmbH

127

NEOS Surgery

Nordson MEDICAL

159

BIOMED® SURGICAL

Novlead Biotech

172

Biotest GmbH & Co. KGaA

OpInstruments GmbH

BrioHealth Technologies

OSTEOBIONIX

154

Cardia Innovation AB

135

Osypka GmbH

102

Cardio Medical GmbH

199

PRRI Cardiothoracic

Cardio Surgical Ltd

133

Qualiteam - Products to Advance Recovery

CARL.

Redax

100

CARMAT

147

ROCOR MEDICAL

Chalice Medical

128

Santec Atramat

Changzhou Ankang Medical Instruments Co., Ltd.(CAK)

Scanlan International, Inc.

CORCYM

SCTS - Society for Cardiothoracic Surgery

166

CTSNet

SERAG-WIESSNER GmbH & Co. KG

118

DELACROIX-CHEVALIER

137

Shanghai XINCHANG Memory Alloy Technology

160

Dendrite Clinical Systems

Simurghy

Designs for Vision

Sinapi Biomedical

DIMEDA Instrumente GmbH

SmartCanula

Dr. Franz Koehler Chemie GmbH

SpectroCor

Geister Medizintechnik GmbH

SS Innovations

EACTS - The European Association For Cardio-Thoracic Surgery

STS - The Society Of Thoracic Surgeons

167

Edwards Lifesciences

Sunoptic Technologies

enableCV

SURGIMED

ESTS

162

Teleflex

130

Eurosets

Exstent Limited

105

Terumo Aortic

FEHLING INSTRUMENTS GmbH

Terumo Cardiovascular

FIAB

TI MEDICAL PRIVATE LIMITED

Fresenius Medical Care Germany GmbH

138

TJ WELCOME MEDICAL EQPT.

103

Fuji Systems

Transonic Europe BV

136

Geister Medical

USB Medical

Genesee BioMedical, Inc.

Vivostat

129

Getinge

Waston Medical

Grena Ltd

WEGO GROUP

Haemonetics

Wexler Surgical

HEMONART

Wisepress

173

HMT Medizintechnik GmbH

XENOSYS

HXCORMED

170

XVIVO

106

International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS)

169

Zimmer Biomet

INTUITIVE

VENTURA MEDICAL TECHNOLOGIES

153

AATS – American Association for Thoracic Surgery

133

appreciation to the many companies that have supported EACTS throughout its

Exhibitor Company Name

ENTRANCE

offer a dedicated networking area, complete with a foosball table, providing the

and evolution of the Association over the past four decades.

opportunities for learning, networking and discovery. We are also pleased to

As we celebrate this landmark anniversary, we extend our sincere

The exhibition floor is as vibrant and dynamic as ever, creating countless

Issue 3 Saturday 10 October 17

Welcome to all our new EACTS Members!

New Members Name

Country

Name

Country

Name

Country

Name

Country

Name

Country

Name

Country

Name

New Members Country

Name

Country

Name

Country

Abdul Baseer Wardak

AFGHANISTAN

Yoshihisa Shimada

CAMBODIA

Tarek El Feky

EGYPT

Terezia Andrasi

GERMANY

Klein Dantis

INDIA

Daniele Calzaferri

IRELAND

Yu Kawahara

JAPAN

Guy Custers

NETHERLANDS

Karolina Rucińska

POLAND

Lindita Çoku

ALBANIA

Charles Mve Mvondo

CAMEROON

Maged Shady

EGYPT

Julia Bendel

GERMANY

Shamanth Kashyap

INDIA

Patrick Higgins

IRELAND

Satoshi Otake

JAPAN

Dolores Koorndijk

NETHERLANDS

Pawel Zelechowski

POLAND

Albi Fagu

ALBANIA

William Santoire

CANADA

Ali Warda

EGYPT

Osama Gargum

GERMANY

Varun Muthu

INDIA

Vivekananda Siddiah

IRELAND

Khalid Abuelsamen

JORDAN

Maaike Van Huis

NETHERLANDS

Joanna Sliwka

POLAND

Indri Bibaja

ALBANIA

Ateeque Siddique

CANADA

Abdallah Nosair

EGYPT

Ilia Bazhanov

GERMANY

Akshaya Singh

INDIA

Jubran Al Balushi

IRELAND

Lijalem Garba

KENYA

Massimo Mariani

NETHERLANDS

Nuno Costa

PORTUGAL

Zina Otmani

ALGERIA

Lucrece Petnga

CANADA

Mohaned Radwan

EGYPT

Kursat Kirkgoz

GERMANY

Rishi Tiwari

INDIA

Steve Okwu

IRELAND

Tamba Martin Mattia

KENYA

Herman Tolboom

NETHERLANDS

Francisca Montenegro

PORTUGAL

Astrid Antonella Ramos

ARGENTINA

Regan Duffy

CANADA

Rana Elbayar

EGYPT

Godswill Oko

GERMANY

INDIA

Cathal Rafferty

IRELAND

Gilbert Oburu

KENYA

Sailay Siddiqi

NETHERLANDS

Tiago Nolasco

PORTUGAL

Guillermo Gutierrez

ARGENTINA

Jennifer Mcdonald

CANADA

Hossam Fouda

EGYPT

Regina Schleicher

GERMANY

Chandan Kumar Ray Mohapatra

Ronan J Ryan

IRELAND

Blend Bejiqi

KOSOVO

Aishat Olowoyeye

NIGERIA

Ana Margarida Rocha

PORTUGAL

Katherine Lopez

ARGENTINA

Linrui Guo

CANADA

Noha Fouda

EGYPT

Ahmed Jaafar Sadeq

GERMANY

Wen Zhou Wang

IRELAND

Tadas Abartis

LITHUANIA

Sarah Fatukasi

NIGERIA

Luis Moura

PORTUGAL

Hatem Elkady

AUSTRALIA

John Moore

CANADA

Sameh Sersar

EGYPT

Cynthia Aucella

GERMANY

Joseph Dilworth

IRELAND

Dominykas Budrys

LITHUANIA

Kenneth Christian

NIGERIA

Cátia Silva

PORTUGAL

Jason Varzaly

AUSTRALIA

Rashmi Nedadur

CANADA

Mahmoud Soliman

EGYPT

Christina Lohrenz

GERMANY

Joseph Murphy

IRELAND

Radvile Kadyte

LITHUANIA

Ayse Suslu

NORWAY

Mariana Campos

PORTUGAL

Jai Raman

AUSTRALIA

Felix Ma

CANADA

Mohamed Zahran

EGYPT

Henriette Most

GERMANY

Machaela Miskell

IRELAND

LUXEMBOURG

Sama Alhabsi

OMAN

Dina Alwaheidi

QATAR

Asen Ivanov

AUSTRALIA

Navneet Kang

CANADA

Ahmed Elkafoury

EGYPT

Hauke Winter

GERMANY

ISRAEL

Tahir Raza

PAKISTAN

Corneliu Vlas

ROMANIA

Michelle Ng

AUSTRALIA

Oscar Blanco Herrera

CANADA

Rania Mostafa

EGYPT

Olger Kraja

GERMANY

Mohammed Waheed Sultan

Yael Ag-Rejuan

Eugen Raul Mihaita Doroftei

INDIA

Gil Bolotin

ISRAEL

PAKISTAN

Scutaru Georgiana

ROMANIA

Jessica Tong

AUSTRALIA

Renee Fournier

CANADA

Karim Elmesery

EGYPT

Juelide Elmali

GERMANY

Saraansh Bansal

INDIA

Francesca Zanin

ITALY

Muhammad Raza Sarfraz

Bianca Gheorghiu

ROMANIA

Eduard Limonjiani

AUSTRALIA

Subodh Verma

CANADA

Khalid Abd Elgawad

EGYPT

Konstancja Porzycka

GERMANY

Mohammed Motiwala

INDIA

Adriano Papagni

ITALY

Dan Mihalcescu

ROMANIA

Shenghao Jiang

AUSTRALIA

Michael Zarathuscook

CANADA

Ahmed Fadaly

EGYPT

Zakaria Msallati

GERMANY

Mahendranath Prasad

INDIA

ITALY

Adrian Popa

ROMANIA

Vincent Le

AUSTRALIA

Hina Inam

CANADA

Mikko Uimonen

FINLAND

Carina Ciobotaru

GERMANY

Mohit Rana

INDIA

Antonio Davide Conserva

Ilie Zotea

ROMANIA

Anthony Tegg

AUSTRALIA

Ricky Muller Moran

CANADA

Fahad Almutairi

FRANCE

Andres Lezama Armenta

GERMANY

G N Lone

INDIA

Alexandra Bordianu

ROMANIA

Zeynep Gulben Kuk Ozalp

AUSTRALIA

Hanmei Li

CHINA

Jean Dubrez

FRANCE

Matthias Raschpichler

GERMANY

Riju Nair

INDIA

Nikita Chibisov

RUSSIA

Li Xiao Qiang

CHINA

Louis Labrousse

FRANCE

Emir Prashovikj

GERMANY

Mohammed Wahaj Ali

INDIA

Sofia Glukhova

RUSSIA

Leifu Shen

CHINA

Nicolas Dostrevy

FRANCE

Ahati Aren

GERMANY

Vinaypraveen Ayyala

INDIA

Daniil Murylev

RUSSIA

Hua Lu

CHINA

Valeria Stati

FRANCE

Ivana Mitrovic

GERMANY

Harish Badami

INDIA

Muslem Almusawi

SAUDI ARABIA

Weidong Li

CHINA

Emeline Plubel

FRANCE

Ahmad Ali

GERMANY

Manjunath Bale

INDIA

Saif Alshaikhmubarak

SAUDI ARABIA

Hongfei Xu

CHINA

Sandrine Dackam

FRANCE

Yelyzaveta Sitnikova

GERMANY

Ramesh Babu Bommaji

INDIA

Toga Ahmed

SAUDI ARABIA

Chengxin Zhang

CHINA

Marie Anne Barbier

FRANCE

Lorenz Veggetti

GERMANY

Sudheer Gandrakota

INDIA

Osman Al-Radi

SAUDI ARABIA

Chenyang Dai

CHINA

Beltran Levy Praschker

FRANCE

Kostiantyn Kozakov

GERMANY

Satya Sridhar Kale

INDIA

Norah Albugami

SAUDI ARABIA

Jian Ding

CHINA

Guillaume Guimbretiere

FRANCE

Josephina Haunschild

GERMANY

INDIA

Suha Althibait

SAUDI ARABIA

Zhi Liu

CHINA

Maiolino Elena

FRANCE

Benjamin Bierbach

GERMANY

Nareshkumar Kalludi Lakshminarasappa

Alwaleed Althobaiti

SAUDI ARABIA

Yu Feng

CHINA

Pietro Messi

FRANCE

Yassine Bennani

GERMANY

SAUDI ARABIA

Rong Zhou

CHINA

Yean Sophea

FRANCE

Mihnea Ghinescu

GERMANY

Venkata Sreedatta Sarraju

Hatem Elmontaser

INDIA

Hani Mufti

SAUDI ARABIA

COLOMBIA

Aurelien Vallee

FRANCE

Christian Liewald

GERMANY

Rhazane Nalluri

INDIA

Ivana Đurošev

SERBIA

COLOMBIA

Jacques Tomasi

FRANCE

Fabian Hundertmark

GERMANY

Levaka Reddy

INDIA

Aludaat Chadi

FRANCE

Lusine Baziiants

GERMANY

Mohammad Hafiz

INDIA

Michel Kindo

FRANCE

Isabel Baldizon Ibarra

GERMANY

Maulik Sharma

INDIA

Saade Saade

FRANCE

Penelope Adinku

GHANA

Lalitaditya Malik

Irakli Khelaia

GEORGIA

GHANA

Dina Markhulia

GEORGIA

Kenneth Kekeli Kuetsidzo

Nana Sichinava

GEORGIA

Loukia Alexopoulou Prounia

GREECE

Ajay Moza

GERMANY

Dimitris Altis

Stefan Erler

GERMANY

Helena Kirr

Sakic Adel

AUSTRIA

Jakob Hirsch

AUSTRIA

Jessica Gottsberger

AUSTRIA

Wolfgang Dietl

AUSTRIA

Martina Hoeftberger

AUSTRIA

Albert Hannover

AUSTRIA

Sarah Linnemeier Jose Ramon Matilla Jennifer Stabernak Laurenz Wolner Josef Helm

AUSTRIA AUSTRIA AUSTRIA AUSTRIA AUSTRIA

Kamal Agarzayev

AZERBAIJAN

Alvaro Martinez Santacruz

Zarifa Badalova

AZERBAIJAN

Carmen Pabon

Rajeebshankar Karmakar

BANGLADESH

Golam Mursalin

BANGLADESH

M Asmaul Nur

BANGLADESH

Md Masud Ur Rashid

BANGLADESH

Kazi Rimo

BANGLADESH

Marina Bushkevich

BELARUS

Ward Seurs

BELGIUM

Haddani Othmane

BELGIUM

Lukman Boutasmit

BELGIUM

Elisa Cornet

BELGIUM

Nicholas Rennie

BELGIUM

Gilles Soenens

BELGIUM

Sophie Bonni

BELGIUM

Oksana Manoryk

BELGIUM

Michaela Orlitova

BELGIUM

Tom Verbelen

BELGIUM

Danae Halleux

BELGIUM

Laurie Stiennon

BELGIUM

Manuel Pirotte

BELGIUM

Milana Klymenko

BOSNIA AND HERZEGOVINA

Heitor Gonzaga

BRAZIL

Gabriela Ruiz

BRAZIL

Jose Renato Torrano Jr

BRAZIL

Marcio Lacerda

BRAZIL

Patricia Viana

BRAZIL

Everton Abegg

BRAZIL

Guilherme Krawczun

BRAZIL

Caroline Lopes Machado

Jaime Arroyo

COLOMBIA

Carlos Chaves Flores

COSTA RICA

Kai Unfried Ana Varela Moreno Christophe Meneas

COSTA RICA COSTA RICA COTE D'IVOIRE

Sinisa Bogovic

CROATIA

Igor Lekšan

CROATIA

Zlatko Marovic

CROATIA

Mislav Planinc

CROATIA

Gloria Sestan

CROATIA

Nikola Slišković

CROATIA

INDIA

Mohammed Idhrees

INDIA

Ezhilan Subramanian

INDIA

Soumyajit Das

INDIA

Venkata Ketana

INDIA

Cristina Arangino

ITALY

Paolo De Orchi

ITALY

Paolo Albino Ferrari Simone Spano

ITALY ITALY

ITALY

Amin Ullah

PAKISTAN

Andrea Nenna

ITALY

Valeria Berti

ITALY

Antonella Dalonzo Anna Rita Manca Rosa Alba Mozzillo

ITALY ITALY ITALY

ITALY

Satyajit Samal

INDIA

Luigi Pellegrino

Mohit Rakhecha

INDIA

Pranav Vempati

GREECE

Michail Argyriou

GERMANY

Tatiana Farb

EGYPT

Jui Hsiang Chen

TAIWAN

Hofiz Yuldoshev

TAJIKISTAN

Godwin Sharau

TANZANIA

Thiti Chanmayka

THAILAND

Chanapong Kittayarak

THAILAND

Parinya Leelayana

THAILAND

Boonlawat Homvises

THAILAND

Wichayane Chotivanich

THAILAND

Peerapat Kongmalai

THAILAND

Termsiri Aittiwarapoj

THAILAND

Pathara Densiridecha

THAILAND

Piyawat Lertsomboon

THAILAND

Punnarerk Thongcharoen

THAILAND

Kasisak Luangpatomaram

THAILAND

GREECE

Vijayant Devenraj

INDIA

Massimo Salardino

ITALY

Sohail Saqib

PAKISTAN

Ilija Bjeljac

SERBIA

GERMANY

John Kokotsakis

GREECE

Saurav Gupta

INDIA

Stefano Pelenghi

ITALY

Prerna Rani

PAKISTAN

Xue Wei Chan

SINGAPORE

Sulejman Abdusalamov

GERMANY

Vasileios Kollias

GREECE

Iresh Shetty

INDIA

Giuseppe Imperatore

ITALY

Mudassar Hussain

PAKISTAN

Md Sazzad

SINGAPORE

Melik Atmaca

GERMANY

Efthymia Liaretidou

GREECE

Sabita Jiwnani

INDIA

Simone Tombelli

ITALY

Moath Hattab

PALESTINE

Kok Hooi Yap

SINGAPORE

Hasan Alkhatib

PALESTINE

Maros Kostial

SLOVAKIA

Hamad Madi

PALESTINE

Richard Kovac

SLOVAKIA

PALESTINE

Anton Tisoncik

SLOVAKIA

Laura Vidmar

SLOVENIA

Maja Bocek

SLOVENIA

Tomislav Klokocovnik

SLOVENIA

Abdijalil Ali

SOMALIA

Andrea Tonelli

SOUTH AFRICA

Tummarat Ruangpratyakul

THAILAND

Jacques Van Wyk

SOUTH AFRICA

Teera Simapattanapong

THAILAND

Kopano Mmalane

SOUTH AFRICA

Penprang Suwannapong

THAILAND

Delroy Musiyarira

SOUTH AFRICA

Phiphat Lochingchairit

THAILAND

Chang-Ha Lee

SOUTH KOREA

Pongpon Munsittikul

THAILAND

Hyo Yeong Ahn

SOUTH KOREA

Nasser Khaoula

TUNISIA

Myeongsu Kim

SOUTH KOREA

Hacı Ucak

TURKEY

Inha Kim

SOUTH KOREA

Ilknur Aydar

TURKEY

Yujin Kwak

SOUTH KOREA

Endri Balla

TURKEY

Ha Lee

SOUTH KOREA

Ozun Bayramlik

TURKEY

Samina Park

SOUTH KOREA

Elif Bicer

TURKEY

Victor X Mosquera Rodriguez

SPAIN

Mehmet Cakici

TURKEY

Gulfem Cakmak

TURKEY

ITALY

Omar Sadek

TAIWAN

Kyriakos Bellos

Sara Saltarocchi

EGYPT

TAIWAN

Chen-Yen Chien

SERBIA

INDIA

Beshoy Moris

Taiwei Chen

Jana Milojevic

Vivek Jaswal

BULGARIA

TAIWAN

PAKISTAN

GREECE

Svetoslav Stoyanov

SWITZERLAND

Shao Jung Li

Atif Nawaz

Ioannis Apergis

EGYPT

Lea Steiner

ITALY

GERMANY

Mostafa Abdelhafeez

SWITZERLAND

Marco Moscarelli

Karen Hornung

BULGARIA

SWITZERLAND

Sylvia Spiesshofer

INDIA

ITALY

Arulkumar Keirthanan

SWITZERLAND

Samuel Khatchatourov

Vinitha Nair

Silvia Romiti

EGYPT

Cem Kapkin

GREECE

INDIA

Hazem Ahmed

SWITZERLAND

SERBIA

Vaibhav Mishra

BRAZIL

SWITZERLAND

Freya Jenkins

Aleksandar Kamenov

GREECE

Jessica Silverio

Dragan Odavic

PAKISTAN

Emmanouil Matalliotakis

EGYPT

SWITZERLAND

Syeda Rabia Mahmood

GERMANY

Omar Galal

SWITZERLAND

Simon Hoerstrup

ITALY

Emmanuel Walter

BRAZIL

Nicola Dotto

Khalil Fattouch

ITALY

Ellton Cavalcanti Dos Santos

SWITZERLAND

INDIA

Alessandro Ricci

ECUADOR

SWITZERLAND

Amine Benouhiba

Kumar Saurabh Gaur

INDIA

Monica Gilbert

SWITZERLAND

Sébastien Colombier

SERBIA

Vishesh Sharma

BRAZIL

Thorsten Krueger

Aleksandar Milutinovic

GREECE

Stephanie Senna

SWITZERLAND

PAKISTAN

Chrysanthi Manali

ECUADOR

SWITZERLAND

Stephanie Mckeown

Rizwan Ullah

GERMANY

Guillermo Solorzano

Aristotelis Panos

ITALY

Lisa Harling

BRAZIL

SWITZERLAND

Fares Shamshoum

ITALY

Kaua Oliveira Da Silva

SWITZERLAND

Thanh-Long Nguyen

INDIA

Martina Mortillaro

Gilmer Romero

Kai Münker

SERBIA

INDIA

BRAZIL

SWITZERLAND

Aleksandar Milosavljevic

Nitin Prakash Kochar

Alessandro Mariani

SWITZERLAND

Robin Willixhofer

PAKISTAN

GREECE

DOMINICAN REPUBLIC

SWITZERLAND

Peter Matt

Jamil Rehman

Theodoros Milas

DENMARK

Elena Kraemer

MEXICO

GERMANY

Finn Dittberner

SWITZERLAND

Juan Camilo Valencia Gaviria

Vanessa Zwaans

BRAZIL

SWITZERLAND

Can Keskinaslan

ITALY

Guilherme Kriger

Dominik Flury

Andrea Dellamore

Riccardo Magni

DENMARK

SWITZERLAND

SERBIA

INDIA

Hanna Dagnegaard

SWITZERLAND

Driton Bajrami

Miroslav Milicic

Pranav Mali

DENMARK

SWITZERLAND

Leon Mitoulas

PAKISTAN

GREECE

Mustafa Ahmad

Yujin Haller

Aizaz Khattak

Eirini Tsilivakou

BRAZIL

SWEDEN

MEXICO

GERMANY

Andressa Da Silva Elicker

SWEDEN

Zineb Chaabi

Victor Sanchez Sotelo

Anna Stegmann

DENMARK

Angiza Shahim

ITALY

Joakim Grant Fredriksen

SWEDEN

SERBIA

Roberta Iacobelli

BRAZIL

SERBIA

SWEDEN

Ibrahim Nauf

Vladimir Milicevic

INDIA

Pedro Cosac

Nemanja Karamarkovic

Mohammed Fakhro

PAKISTAN

Fredrick Clifford Selvam

DENMARK

PAKISTAN

SWEDEN

Afnan Fayaz

GREECE

Sana Buttar

Zain Abedin

SPAIN

Marten Larsson

MEXICO

Antonios Samothrakis

BRAZIL

SERBIA

SPAIN

Diana Batin

Lorena Nayeli Ramos

GERMANY

Maira Fernandes

Maja Ercegovac

Jose Villaescusa

SERBIA

Carla L Schuering

DENMARK

PAKISTAN

SPAIN

Aleksandar Mikic

ITALY

Hussein Nasser Awada

Muhammad Haseeb Mumtaz

Marta Domingo Rivas

PAKISTAN

Gianluca Brancaccio

BRAZIL

Gloria Ortiz Betance

SPAIN

Niaz Ali

INDIA

Paulo Amorim

MEXICO

PAKISTAN

Jose Manuel Martínez Comendador

MEXICO

Nakul Babu

DENMARK

PAKISTAN

Samreen Malik

Country

Luis Arturo Ramirez Valdivia

GREECE

Benjamin Kelly

Syed Bukhari

MEXICO

Georgios Pilichos

BRAZIL

PAKISTAN

Jesus Infante

GERMANY

Rodrigo Tchaick

Amna Abbas

MEXICO

ITALY

Emilija Miskinyte

DENMARK

Rene Soberanis Gervacio

Giovanni Leuzzi

Mariafrancesca Fiorentino

PAKISTAN

MEXICO

INDIA

Shakir Ullah

Laura Rodriguez

Annet Cazares Perez

ITALY

PAKISTAN

MEXICO

ITALY

Cristina Viola

Hosh Muhammad

Emmanuel Enrique Armenia

Carlo Ferronato

ITALY

Evald Christiansen

Sunsiarey Henry

MEXICO

Ermanno Bellanti

BRAZIL

PAKISTAN

Omar Victorica

INDIA

Felipe Spadini

Waqar Malak

ITALY

Arohi Jain

DENMARK

PAKISTAN

Mauro Del Giglio

GREECE

Kamran Hosseinzadeh

Waqar Khan

PAKISTAN

Vasileios Patris

BRAZIL

MALAYSIA

PAKISTAN

Nazish Sikander

GERMANY

Pedro Rondinelli

Ahmad Mahir Shamsuddin

Sara Hussain

MAURITIUS

Yaroslav Ivanov

CZECH REPUBLIC

MALAYSIA

PAKISTAN

Mohammad Sohawon

Arshi Jain

David Vician

Ng Ern

Ikram Hassan

ITALY

BRAZIL

MALAYSIA

Valentina Aloi

Riccardo Bei

Vaclav Maly

Saravana Karupiah

MARTINIQUE

Sara Bravin

INDIA

CZECH REPUBLIC

MALAYSIA

PAKISTAN

Amjad Shaikh

Towa Miyata

Nur Shahkizza Mohd Jefry

PAKISTAN

GREECE

CZECH REPUBLIC

PAKISTAN

Somia Razzaq

Alkinoos Nikolis

Mirabubakr Mirkomilov

PAKISTAN

Mahwish Bhutta

Diyan Muhammad

GERMANY

Anton Maksymenko

Athar Khan

MARTINIQUE

Zipan Fan

CZECH REPUBLIC

MALAYSIA

Sunsiarey Henry

CZECH REPUBLIC

Dushan Kolesar

Rashid Radzif

ITALY

CZECH REPUBLIC

PAKISTAN

Marilena Drago

Penelope Semple

CZECH REPUBLIC

Syeda Ruqaiya

PAKISTAN

INDIA

Ales Klvacek

MADAGASCAR

Misauq Mazcuri

Bijoy Kutty

CZECH REPUBLIC

Ravaoavy Hariniaina

MALTA

GREECE

Jan Coufal

MACEDONIA

Nathan Zammit

Fotios Mitropoulos

CZECH REPUBLIC

Marko Minovski

LUXEMBOURG

ITALY

GERMANY

Jan Burkert

Sergiu Cebotari

Pierpaolo Fortunato

Miyoung Cho

CZECH REPUBLIC

18 EACTS DAILY NEWS

Vijit Cherian

CUBA

CZECH REPUBLIC

BRAZIL

INDIA

Massiel De La Rosa Castillo

Lea Wittlinger

Monica Louise Lima

Sameer Ummer

Name

Sonja Meissner

GERMANY

Ioanna Galanopoulou

GREECE

Pramoda Hari

INDIA

Mattia Vinciguerra

ITALY

Luca Paolo Weltert

ITALY

Martina Ziantoni

ITALY

Said Baris

MOLDOVA

Mara Djurovic

MONTENEGRO

Fatima Zahra Ammor

MOROCCO

Soukaina Benbakh

MOROCCO

Badreddine Belayachi

MOROCCO

Yassin Elmourabit

MOROCCO

Salma El Manir

MOROCCO

Meryeme Grine

MOROCCO

Hatim Yousfi

MOROCCO

K Khaing Saw Lwin

MYANMAR

Mohammad Eid Mohtasib

Niraj Bhattarai

NEPAL

Luis Aguirre Tipismana

PERU

Deepak Magar

NEPAL

Jose Conde

PERU

Sagar Khatiwada

NEPAL

Luz Rosadio

PERU

Manish Acharya

NEPAL

Harod Silva Tejada

PERU

Krishnaprasad Bashyal

NEPAL

Brigitte Tarazona

PERU

Bikash Shah

NEPAL

Alex Valdivia

PERU

Mike Gartside

NETHERLANDS

Sergio Zavala

PERU

Jojanneke KraaijeveldVan Den Beukel

NETHERLANDS

Luis Zavaleta

PERU

Neil Christian Villamucho

PHILIPPINES

Nicko Olermo

PHILIPPINES

John Kevin Kim Dela Cruz

PHILIPPINES

Fabienne Plaßmeier

GERMANY

Nikolaos Antonopoulos

GREECE

Ashiq Nihmathullah

Jana Sattelmair

GERMANY

Omiros Chalvatzoulis

GREECE

Hemachandren Munuswamy

INDIA

Tanushree Kar

INDIA

Ashish Khanijo

INDIA

Furkan Sayyad

INDIA

Pranay Mehsare

INDIA

Shahir Vardhan Reddy Kasi Reddy

Yusuke Ando

JAPAN

Merel Jans

NETHERLANDS

INDIA

Masato Furui

JAPAN

Fay Claybrook

NETHERLANDS

INDIA

Yusuke Nakata

JAPAN

Alaa Maali Natacha Jalu

GERMANY GERMANY

Tien Chen Tu Peng

GUATEMALA

Michael Hsin

HONG KONG

Marianne Thoenes

GERMANY

Yiu Tung Matthew Wong

HONG KONG

Hussam Imadi

GERMANY

Christy Wong

HONG KONG

Saha Harant Ilias Arfanis

GERMANY GERMANY

Mohammad Mehdi Dehghani Firoozabadi

GERMANY

Elham Mansour Safaeyan

GERMANY

Carl Philipp Bittorf

GERMANY

Mohamed Haj Khalaf

GERMANY

Presheet Pathare

GERMANY

Mahmod Ammar

GERMANY

Joyjit Singh

GERMANY

Imre Barabás

HUNGARY

Viktória Bognár

HUNGARY

Levente Bogyo

HUNGARY

Nicolas Alexander Toranosuke Kato

HUNGARY

Heajung Ryu

HUNGARY

Hanna Tihanyi

HUNGARY

Wan Chin Hsieh

Nagesh Basavaraj Nikunjkumar Shekhada Vipin Nair

INDIA

INDIA INDIA

John Neeraj Wesley

INDIA

HUNGARY

Divva Azhalisita Amelinda

INDONESIA

Miklos Bitay

HUNGARY

Gassani Amalia

INDONESIA

Tómas Kristjánsson

ICELAND

Reynold Siburian

INDONESIA

Rajan Modi

INDIA

Esmail Asdaghpour

IRAN

Pranjal Banthia

INDIA

Alireza Ghavidel

IRAN

Vishal Gupta

INDIA

Mehrdad Salehi

IRAN

Elina Oesterhaus

GERMANY

Maria Elisa Saavedra Meza

GERMANY

Mariana Shumliakivska

GERMANY

Kunal Jain

INDIA

Shkar Raouf Haji Saeed

IRAQ

Laurin Micek

GERMANY

Anil Jain

INDIA

Fahmi Kakamad

IRAQ

Julius Borger

GERMANY

Kush Bhatt

INDIA

Arian Mahmoud

IRAQ

Aline Rentschler

GERMANY

Vikas V

INDIA

Kornelija Bajoraityte

IRELAND

Kim Stoecker

GERMANY

A Mughilan

INDIA

Illann Wall

IRELAND

Svetla Chilikova

GERMANY

Bharathi Bhat

INDIA

Lorraine Browne

IRELAND

Mariateresa Femia Maria Serena Menzione

ITALY ITALY

Priscilla The

NETHERLANDS

Tijn Heeringa

NETHERLANDS

Olga Papazisi

NETHERLANDS

Piergiorgio Bruno

ITALY

Pascal Govers

NETHERLANDS

Gabriella Bonioli

ITALY

Arash Dodge

NETHERLANDS

Masayuki Shimizu Noritoshi Minematsu

JAPAN JAPAN

Kenta Higashi

JAPAN

Kazuhiro Ueda

JAPAN

Motonori Ishido

JAPAN

Kazuma Handa

JAPAN

Ryu Kanzaki

JAPAN

Yusuke Motoji

JAPAN

Takanobu Kimura

JAPAN

Yoshiki Watanabe

JAPAN

Ryoma Oda

JAPAN

Hideyuki Kato

JAPAN

Daiki Saito

JAPAN

Jun Hayashi

JAPAN

Ridha Alnuwaysir

NETHERLANDS

Elyan Ruiz Solano

NETHERLANDS

Andre Van Der Mee Mendes

NETHERLANDS

Christian Vroegh

NETHERLANDS

Mounir Bourass

NETHERLANDS

Ferdinand Bruning

NETHERLANDS

Vincent Sier

NETHERLANDS

Bart Velders

NETHERLANDS

George Ayoub

NETHERLANDS

Kinsing Ko

NETHERLANDS

Elise Cevaal Poortvliet

NETHERLANDS

Marie Jose De Hartog

NETHERLANDS

Lydia Allemekinders

NETHERLANDS

Sepideh Banar

NETHERLANDS

Laurent Coopmans

NETHERLANDS

Christine Carmelle Esplana

PHILIPPINES

Mikolaj Chmielnicki

POLAND

Andrzej Gnilka

POLAND

Mateusz Janeczek

POLAND

Michal Kuten

POLAND

SPAIN

Julia Ogrodowczyk Vel Ogrodowicz

Jhonny Javier Montesino Villafranca

Kerem Demir

TURKEY

POLAND

Ana Solbes Molto

SPAIN

Okay Karaca

TURKEY TURKEY

Pawel Slozowski

POLAND

Carla Gotsens Asenjo

SPAIN

Arif Karslioglu

Roch Pakuła

POLAND

Rosa Peiro Osuna

SPAIN

Umit Kervan

TURKEY

Dorota Wozniak

POLAND

Remedios Ríos

SPAIN

Ufuk Keskin

TURKEY

Oktawiusz Mirecki

POLAND

Gökhan Kocaman

TURKEY

POLAND

Narda Waleza Ajhuacho Renteria

SPAIN

Wojciech Wiese

Alvaro Alvarez Tomas

SPAIN

Muhammet Sefa Saglam

TURKEY

Nicolas Moreno Mata

SPAIN

Isil Tasoz Ozdas

TURKEY

Maria Solis

SPAIN

Umutcan Ulusoy

TURKEY

Jean Carlo Olivo Soto

SPAIN

Levent Yazicioglu

TURKEY

Carlos Porras

SPAIN

Yigit Yilmaz

TURKEY

Lorena Rubio

SPAIN

Okan Yurdakok

TURKEY

Ali Yener

TURKEY

Hilal Dogangun

TURKEY

Lucas Moskal

POLAND

Michal Graczyk

POLAND

Katarzyna Żanowska

POLAND

Seweryn Grudniewicz

POLAND

Michal Pawlikow

POLAND

Tomasz Semań

POLAND

Eryk Trela

POLAND

Lina Bengherbia

POLAND

Issue 3 Saturday 10 October 19

New Members Name

Country

Name

Country

Name

Country

Marta Domingo Rivas

SPAIN

Secil Ozturk Kucuker

TURKEY

Samir Mirzoiev

UKRAINE

Jose Villaescusa

SPAIN

Osman Akpinar

TURKEY

Pavlo Radzikhovskyi

UKRAINE

Diana Batin

SPAIN

Ayse Ali Hasan

TURKEY

Daniel Rusnak

UKRAINE

Marten Larsson

SWEDEN

Kemal Kararslan

TURKEY

Sabi Sandu

UKRAINE

Mohammed Fakhro

SWEDEN

Senanur Duymaz

TURKEY

Mykhailo Semenets

UKRAINE

Ibrahim Nauf

SWEDEN

Meril Ahmet

TURKEY

Matviyan Shymon

UKRAINE

Angiza Shahim

SWEDEN

Feyza Alkilic

TURKEY

Rodion Skvarskyi

UKRAINE

Zineb Chaabi Yujin Haller

SWEDEN SWITZERLAND

Zinar Apaydin Mariam Arafa

TURKEY TURKEY

Andrii Stepaniuk Mykhailo Todurov

UKRAINE

SWITZERLAND

Aslanbek Arziev

TURKEY

Kyrylo Tsyhalko

UKRAINE

Driton Bajrami

SWITZERLAND

Mohamad Kenan Atasi

TURKEY

Dariia Vinnichenko

UKRAINE

Dominik Flury

SWITZERLAND

Osman Murat Bastopcu

TURKEY

Denis Voropaiev

UKRAINE

Can Keskinaslan

SWITZERLAND

Busra Bastopcu

TURKEY

Andrii Sydiuk

UKRAINE

Elena Kraemer

SWITZERLAND

Selin Can

TURKEY

Rostyslav Tsinyk

UKRAINE

Peter Matt

SWITZERLAND

Funda Cansun

TURKEY

Yurii Behei

UKRAINE

Robin Willixhofer

SWITZERLAND

Bedirhan Cevik

TURKEY

Rasim Budahov

UKRAINE

Kai Münker

SWITZERLAND

Deniz Cevirme

TURKEY

Maxym Khudas

UKRAINE

Thanh-Long Nguyen

SWITZERLAND

Serkan Deser

TURKEY

Denys Skorokhod

UKRAINE

Aristotelis Panos

SWITZERLAND

Emre Dogan

TURKEY

Yurii Tarasenko

UKRAINE

Stephanie Mckeown

SWITZERLAND

TURKEY

Ahmed Ghobara

Thorsten Krueger

SWITZERLAND

Emine Aleyna Eroglu Polat

UNITED KINGDOM

Sébastien Colombier

SWITZERLAND

Yagmur Esenoglu

TURKEY

Setemi Olufemi

UNITED KINGDOM

Amine Benouhiba

SWITZERLAND

Tirth Shah

Nicola Dotto

SWITZERLAND

UNITED KINGDOM

Simon Hoerstrup

SWITZERLAND

Ching Chi Chu

UNITED KINGDOM

Dragan Odavic

SWITZERLAND

Freya Jenkins

SWITZERLAND

Ambreen Abid

UNITED KINGDOM

Cem Kapkin

SWITZERLAND

Samuel Khatchatourov

SWITZERLAND

Sylvia Spiesshofer

SWITZERLAND

Lea Steiner

SWITZERLAND

Shao Jung Li

TAIWAN

Taiwei Chen

TAIWAN

Chen-Yen Chien

TAIWAN

Jui Hsiang Chen

TAIWAN

Hofiz Yuldoshev

TAJIKISTAN

Godwin Sharau

TANZANIA

Thiti Chanmayka

THAILAND

Chanapong Kittayarak

THAILAND

Parinya Leelayana

THAILAND

Boonlawat Homvises

THAILAND

Wichayane Chotivanich

THAILAND

Peerapat Kongmalai

THAILAND

Termsiri Aittiwarapoj

THAILAND

Pathara Densiridecha

THAILAND

Piyawat Lertsomboon

THAILAND

Punnarerk Thongcharoen

THAILAND

Kasisak Luangpatomaram

THAILAND

Tummarat Ruangpratyakul

THAILAND

Teera Simapattanapong

THAILAND

Penprang Suwannapong

THAILAND

Phiphat Lochingchairit

THAILAND

Pongpon Munsittikul

THAILAND

Nasser Khaoula

TUNISIA

Hacı Ucak

TURKEY

Ilknur Aydar

TURKEY

Endri Balla

TURKEY TURKEY

Elif Bicer

TURKEY

Mehmet Cakici

TURKEY

Gulfem Cakmak

TURKEY

Kerem Demir

TURKEY

Okay Karaca

TURKEY

Arif Karslioglu

TURKEY

Umit Kervan

TURKEY

Ufuk Keskin

TURKEY

Gökhan Kocaman

TURKEY

Muhammet Sefa Saglam

TURKEY

Isil Tasoz Ozdas

TURKEY

Umutcan Ulusoy

TURKEY

Levent Yazicioglu

TURKEY

Yigit Yilmaz

TURKEY

Okan Yurdakok

TURKEY

Ali Yener

TURKEY

Hilal Dogangun

TURKEY

Aysen Yaprak Kapkin

TURKEY

20 EACTS DAILY NEWS

Deniz Gunay

TURKEY

Gokhan Ipek

TURKEY

Berna Karatas Nur Simge Kokles

TURKEY TURKEY

Suha Kucukaksu

TURKEY

Tunc Lacin

TURKEY

Eyup Murat Okten

TURKEY

Suat Nail Omeroglu

TURKEY

Mehmet Onalan

TURKEY

Yunus Ozsaray

TURKEY

Fatma Ozturk

TURKEY

Mehmet Rum

TURKEY

Mahmut Sasani

TURKEY

Mehmet Sengor

TURKEY

Muhammed Serbetci

TURKEY

Ilhan Sesiguzel

TURKEY

Kudret Tekin

TURKEY

Altug Tuncer

TURKEY

Mehmet Turan

TURKEY

Melike Ulker

TURKEY

Hassan Bakali

TURKEY

Yüksel Beşir

TURKEY

Deniz Bozdogan

TURKEY

Chris Bond

UNITED KINGDOM

Ananya Mathur

UNITED KINGDOM

Ivan Yim

UNITED KINGDOM

Krupal Reddy

UNITED KINGDOM

Michael Kay

UNITED KINGDOM

Umberto Benedetto

UNITED KINGDOM

Stamatina Koskolou

UNITED KINGDOM

Zaheer Tahir

UNITED KINGDOM

Mustafa Rady

UNITED KINGDOM

Vincenzo De Franco

UNITED KINGDOM

Shakil Farid

UNITED KINGDOM

Joshua Samuel

UNITED KINGDOM

Samuel Kemp

UNITED KINGDOM

Luis A. HernandezArenas

UNITED KINGDOM

Hind Elhassan

UNITED KINGDOM

Sena Cavus

TURKEY

Sahin Iscan

TURKEY

Musa Manneh

TURKEY

Mete Gursoy

TURKEY

Ceren Yildiz

TURKEY

Mikel Kamami

UNITED KINGDOM

Dilsad Amanvermez Senarslan

TURKEY

Shahid Mehmood

UNITED KINGDOM

Ahmet As

TURKEY

Salih Salihi

TURKEY

Vivin Chrysostor Albert Santhappa

UNITED KINGDOM

Ahmet Kuyucu

TURKEY

Lea Billich

UNITED KINGDOM

Guvanch Charyyev

TURKMENISTAN

Volodymyr Kiritsev

UKRAINE

Ilya Zhushman

UKRAINE

Taras Gudzenko

UKRAINE

Denys Strilchuk

UKRAINE

Rostyslav Zvarychuk

UKRAINE

Tetiana Velyhoria

UKRAINE

Kostiantyn Babych

UKRAINE

Vasil Beleiovych

UKRAINE

Andrii Bulakh

UKRAINE

Khrystyna Chekh

UKRAINE

Kostiantyn Daviskiba

UKRAINE

Diana Dudok

UKRAINE

Sviatoslav Flinta

UKRAINE

Diana Ilchuk

UKRAINE

Yevhenii Kashperskyi

UKRAINE

Ivan Kravchenko

UKRAINE

Oleksandr Kupchynskyi

UKRAINE

Volodymyr Kupchynskyi

UKRAINE

Anhelina Lymar

UKRAINE

Ivan Makohonchuk

UKRAINE

Vladyslav Marchenko

UKRAINE

Andreas Gialeli

UNITED KINGDOM

Mark Kerr

UNITED KINGDOM

Sarah Kelly

UNITED KINGDOM

James Veitch

UNITED KINGDOM

Nizar Asadi

UNITED KINGDOM

Richard Thomson

UNITED KINGDOM

Jose Alvarez Gallesio

UNITED KINGDOM

Muneeb Khalid

UNITED KINGDOM

Hiwa Najmalddin

UNITED KINGDOM

Kosha Patel

UNITED KINGDOM

Garima Bhag

UNITED KINGDOM

Hamad Ahmad

UNITED KINGDOM

Sanjay Chaubey

UNITED KINGDOM

Ishaan Chauhan

UNITED KINGDOM

Mona Dave

UNITED KINGDOM

Name

Country

Archie Egrilmezer

UNITED KINGDOM

Samson Egbulonu

Yuvraj Juttla

UNITED KINGDOM

Rhia Marie Casinillo

UNITED KINGDOM

Umar Masoro

UNITED KINGDOM

Luciano Delbono

UNITED STATES

Elizabeth Norton

UNITED STATES

John Puskas

UNITED STATES

Alex Wang

UNITED STATES

Jordan Bloom

UNITED STATES

Melina Heine

UNITED STATES

David Deboer

UNITED STATES

Sarah Nisivaco

UNITED STATES

Bushray Almiqlash

UNITED STATES

Cristiano Spadaccio

UNITED STATES

Nika Samadzadeh Tabrizi

UNITED STATES

Shinya Unai

UNITED STATES

Peter Kneuertz

UNITED STATES

Sashelin Naidoo

UNITED STATES

Ahmet Bilgili

UNITED STATES

Amjad Syed

UNITED STATES

Nicolas Anzellini

UNITED STATES

Jaymie Claire Henry

UNITED STATES

Felix Tsai

UNITED STATES

Ali Mashadi

UNITED STATES

Chawannuch Ruaengsri

UNITED STATES

Andrea Orellana

UNITED STATES

Amit Bhargava

UNITED STATES

Makoto Mori

UNITED STATES

Brandon Ferrell

UNITED STATES

Ali Hage

UNITED STATES

Jennifer Wilson

UNITED STATES

Calvin Macdonald

UNITED STATES

Elan Burton

UNITED STATES

Bryant Fisher

UNITED STATES

Adriana Hette

UNITED STATES

Defne Gunes Ergi

UNITED STATES

Ariana Goodman

UNITED STATES

Veronica Liang

UNITED STATES

Angela De La Fuente

UNITED STATES

Dawn Jaroszewski

UNITED STATES

Annabella Hochschild

UNITED STATES

Fadi Hage

UNITED STATES

Ramiro Arismendi

URUGUAY

Carolina Sosa Vota

URUGUAY

Olim Khamdamov

UZBEKISTAN

Doniyor Kuchkarov

UZBEKISTAN

Alina Mistirian

UNITED KINGDOM

Younis Peach

UNITED KINGDOM

Jade Qu

UNITED KINGDOM

Sam Raaj

UNITED KINGDOM

Evgeny Raevsky

UNITED KINGDOM

Shruti Rajendra

UNITED KINGDOM

Akhash Rathinam

UNITED KINGDOM

Daniella Ricchiuti

UNITED KINGDOM

Vaishnavi Sabarigirivasan

UNITED KINGDOM

Wafaa S M Shehada

UNITED KINGDOM

Sophia Sood

UNITED KINGDOM

Sanjeevan Sriskandarajah

UNITED KINGDOM

Mirthica Suganthan

UNITED KINGDOM

Selina Tsai

UNITED KINGDOM

Haron Watak

UNITED KINGDOM

Henrietta Wilson

UNITED KINGDOM

Hussain Zaidi

UNITED KINGDOM

Bekzod Isomitdinov

UNITED KINGDOM

Aamir Amin

UNITED KINGDOM

Ahmed Elmezayen

UNITED KINGDOM

Bertram Harrington

UNITED KINGDOM

Mubashar Nadeem

UNITED KINGDOM

Ashwin Phadke

UNITED KINGDOM

Radhe Shantha Kumar

UNITED KINGDOM

Enoch Akowuah

UNITED KINGDOM

Muhammed Hebala

UNITED KINGDOM

Asif Shah

UNITED KINGDOM

Vamsidhar Dronavalli

UNITED KINGDOM

Shakulov Murodulloyevich

UZBEKISTAN

Amr Rushwan

UNITED KINGDOM

Alisher Akbarzoda

UZBEKISTAN

Alisher Akbarzoda

UZBEKISTAN

Khusan Khalikulov

UZBEKISTAN

Nikita Konovalov

UZBEKISTAN

Khondamir Mirzaev

UZBEKISTAN

Murodjon Muhammedov

UZBEKISTAN

Maksud Muradov

UZBEKISTAN

Aziza Tavakkalova

UZBEKISTAN

Farrukh Vohidov

UZBEKISTAN

An Nguyen

VIETNAM

Ayan Arya

UNITED KINGDOM

Stefania Cavaliere

UNITED KINGDOM

Oscar Lu

UNITED KINGDOM

Yasser Khalaf

UNITED KINGDOM

Nikolaos Kostoulas

UNITED KINGDOM

Pablo Gomes Da Silva De Rosenzweig

UNITED KINGDOM

Yin Tung Shanessa Chan

UNITED KINGDOM

Qizong Hayden Huang

UNITED KINGDOM

Aron Abraham

UNITED KINGDOM

Laith Ali

UNITED KINGDOM

Hazem Aljasem

UNITED KINGDOM

Jason Kho

UNITED KINGDOM

Laura Viola

UNITED KINGDOM

Georgios Kechagioglou

UNITED KINGDOM

Shahzad Raja

UNITED KINGDOM

Poorva Zope

UNITED KINGDOM

Nicole Asemota

UNITED KINGDOM

Swapnil Sahoo

UNITED KINGDOM

Anshini Thakur

UNITED KINGDOM

2026

Ozun Bayramlik

TURKEY

Country

UNITED KINGDOM

UKRAINE

Leon Mitoulas

Selinsu Gulesce

Name

Issue 3 Saturday 10 October 21

Recognising 40 outstanding

members under the age of 40!

As we celebrate 40 years of EACTS, we have recognised 40 inspiring EACTS members under the age of 40, who demonstrate a commitment to cardiothoracic surgery and our mission to improve patient outcomes. Following a highly competitive selection process, we’re delighted to share the official members of the EACTS 40 Under 40 initiative. These individuals represent the next generation of leaders whose contributions are advancing patient care, driving scientific innovation and inspiring colleagues across the global cardiothoracic community.

Cardiothoracic surgery is a specialty that demands dedication, resilience, curiosity, and collaboration. To be recognised by EACTS among such an inspiring group of early-career surgeons and researchers is both humbling and motivating. It strengthens my commitment to advancing patient care, contributing to research and innovation, and supporting the future of our specialty. Leila Louise Benhassen

Being included among such an outstanding group of colleagues is both a privilege and a responsibility. I’m sincerely grateful to the mentors, collaborators, colleagues, and patients who have been part of this journey. Every achievement in academic surgery is built on teamwork, shared knowledge, and the pursuit of better outcomes for our patients. Tulio Caldonazo

22 EACTS DAILY NEWS

Issue 3 Saturday 10 October 23

BREAKING BARRIERS BUILDING THE FUTURE

FULL-PAGE ADVERT

Innovate

Discover

Educate